1
|
Pogue JA, Harms JM, Cardenas CE, Ray X, Viscariello N, Popple RA, Stanley D, Boggs DH. Unlocking the adaptive advantage: correlation and machine learning classification to identify optimal online adaptive stereotactic partial breast candidates. Phys Med Biol 2024. [PMID: 38729212 DOI: 10.1088/1361-6560/ad4a1c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2024]
Abstract
OBJECTIVE Online adaptive radiotherapy (OART) is a promising technique for delivering stereotactic accelerated partial breast irradiation (APBI), as lumpectomy cavities vary in location and size between simulation and treatment. However, OART is resource-intensive, increasing planning and treatment times and decreasing machine throughput compared to the standard of care (SOC). Thus, it is pertinent to identify high-yield OART candidates to best allocate resources.
Approach. Reference plans (plans based on simulation anatomy), SOC plans (reference plans recalculated onto daily anatomy), and daily adaptive plans were analyzed for 31 sequential APBI targets, resulting in the analysis of 333 treatment plans. Spearman correlations between 22 reference plan metrics and 10 adaptive benefits, defined as the difference between mean SOC and delivered metrics, were analyzed to select a univariate predictor of OART benefit. A multivariate logistic regression model was then trained to stratify high- and low-benefit candidates.
Main Results. Adaptively delivered plans showed dosimetric benefit as compared to SOC plans for most plan metrics, although the degree of adaptive benefit varied per patient. The univariate model showed high likelihood for dosimetric adaptive benefit when the reference plan ipsilateral breast V15Gy exceeds 23.5%. Recursive feature elimination identified 5 metrics that predict high-dosimetric-benefit adaptive patients. Using leave-one-out cross validation, the univariate and multivariate models classified targets with 74.2% and 83.9% accuracy, resulting in improvement in per-fraction adaptive benefit between targets identified as high- and low-yield for 7/10 and 8/10 plan metrics, respectively.
Significance. This retrospective, exploratory study demonstrated that dosimetric benefit can be predicted using only ipsilateral breast V15 Gy on the reference treatment plan, allowing for a simple, interpretable model. Using multivariate logistic regression for adaptive benefit prediction led to increased accuracy at the cost of a more complicated model. This work presents a methodology for clinics wishing to triage OART resource allocation.
.
Collapse
Affiliation(s)
- Joel Anthony Pogue
- Radiation Oncology, The University of Alabama at Birmingham Department of Radiation Oncology, Hazelrig Salter Radiation Oncology Center, 619 19th Street South, Birmingham, Alabama, 35249-6832, UNITED STATES
| | - Joseph M Harms
- Department of Radiation Oncology, The University of Alabama at Birmingham Department of Radiation Oncology, 1700 6th avenue south, Birmingham, Alabama, 35233, UNITED STATES
| | - Carlos E Cardenas
- Radiation Oncology, The University of Alabama at Birmingham School of Medicine, 1700 6th Avenue South, Birmingham, Alabama, 35233, UNITED STATES
| | - Xenia Ray
- Radiation Medicine & Applied Sciences, University of California San Diego, 3855 Health Sciences Dr. #0843, La Jolla, California, 92093-0843, UNITED STATES
| | - Natalie Viscariello
- Radiation Oncology, The University of Alabama at Birmingham Department of Radiation Oncology, Hazelrig Salter Radiation Oncology Center, 619 19th Street South, Birmingham, Alabama, 35233, UNITED STATES
| | - Richard A Popple
- Radiation Oncology, The University of Alabama at Birmingham Department of Radiation Oncology, Hazelrig Salter Radiation Oncology Center, 619 19th Street South, Birmingham, Alabama, 35233, UNITED STATES
| | - Dennis Stanley
- Radiation Oncology, The University of Alabama at Birmingham Department of Radiation Oncology, Hazelrig Salter Radiation Oncology Center, 619 19th Street South, Birmingham, Alabama, 35233, UNITED STATES
| | - Drexell H Boggs
- Radiation Oncology, The University of Alabama at Birmingham Department of Radiation Oncology, Hazelrig Salter Radiation Oncology Center, 619 19th Street South, Birmingham, Alabama, 35233, UNITED STATES
| |
Collapse
|
2
|
Richardson SL, Bosch WR, Mayo CS, McNutt TR, Moran JM, Popple RA, Xiao Y, Covington EL. Order From Chaos: The Benefits of Standardized Nomenclature in Radiation Oncology. Pract Radiat Oncol 2024:S1879-8500(24)00080-8. [PMID: 38636586 DOI: 10.1016/j.prro.2024.04.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2024] [Revised: 02/28/2024] [Accepted: 04/01/2024] [Indexed: 04/20/2024]
Abstract
Although standardization has been shown to improve patient safety and improve the efficiency of workflows, implementation of standards can take considerable effort and requires the engagement of all clinical stakeholders. Engaging team members includes increasing awareness of the proposed benefit of the standard, a clear implementation plan, monitoring for improvements, and open communication to support successful implementation. The benefits of standardization often focus on large institutions to improve research endeavors, yet all clinics can benefit from standardization to increase quality and implement more efficient or automated workflow. The benefits of nomenclature standardization for all team members and institution sizes, including success stories, are discussed with practical implementation guides to facilitate the adoption of standardized nomenclature in radiation oncology.
Collapse
Affiliation(s)
- Susan L Richardson
- Department of Radiation Oncology, Swedish Medical Center-Tumor Institute, Seattle, Washington.
| | - Walter R Bosch
- Department of Radiation Oncology, Washington University, Saint Louis, Missouri
| | - Charles S Mayo
- Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan
| | - Todd R McNutt
- Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland
| | - Jean M Moran
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Ying Xiao
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
| | | |
Collapse
|
3
|
Kraus AC, Iqbal Z, Cardan RA, Popple RA, Stanley DN, Shen S, Pogue JA, Wu X, Lee K, Marcrom S, Cardenas CE. Prospective Evaluation of Automated Contouring for CT-Based Brachytherapy for Gynecologic Malignancies. Adv Radiat Oncol 2024; 9:101417. [PMID: 38435965 PMCID: PMC10906166 DOI: 10.1016/j.adro.2023.101417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Accepted: 11/30/2023] [Indexed: 03/05/2024] Open
Abstract
Purpose The use of deep learning to auto-contour organs at risk (OARs) in gynecologic radiation treatment is well established. Yet, there is limited data investigating the prospective use of auto-contouring in clinical practice. In this study, we assess the accuracy and efficiency of auto-contouring OARs for computed tomography-based brachytherapy treatment planning of gynecologic malignancies. Methods and Materials An inhouse contouring tool automatically delineated 5 OARs in gynecologic radiation treatment planning: the bladder, small bowel, sigmoid, rectum, and urethra. Accuracy of each auto-contour was evaluated using a 5-point Likert scale: a score of 5 indicated the contour could be used without edits, while a score of 1 indicated the contour was unusable. During scoring, automated contours were edited and subsequently used for treatment planning. Dice similarity coefficient, mean surface distance, 95% Hausdorff distance, Hausdorff distance, and dosimetric changes between original and edited contours were calculated. Contour approval time and total planning time of a prospective auto-contoured (AC) cohort were compared with times from a retrospective manually contoured (MC) cohort. Results Thirty AC cases from January 2022 to July 2022 and 31 MC cases from July 2021 to January 2022 were included. The mean (±SD) Likert score for each OAR was the following: bladder 4.77 (±0.58), small bowel 3.96 (±0.91), sigmoid colon 3.92 (±0.81), rectum 4.6 (±0.71), and urethra 4.27 (±0.78). No ACs required major edits. All OARs had a mean Dice similarity coefficient > 0.86, mean surface distance < 0.48 mm, 95% Hausdorff distance < 3.2 mm, and Hausdorff distance < 10.32 mm between original and edited contours. There was no significant difference in dose-volume histogram metrics (D2.0 cc/D0.1 cc) between original and edited contours (P values > .05). The average time to plan approval in the AC cohort was 19% less than the MC cohort. (AC vs MC, 117.0 + 18.0 minutes vs 144.9 ± 64.5 minutes, P = .045). Conclusions Automated contouring is useful and accurate in clinical practice. Auto-contouring OARs streamlines radiation treatment workflows and decreases time required to design and approve gynecologic brachytherapy plans.
Collapse
Affiliation(s)
- Abigayle C. Kraus
- Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama
| | - Zohaib Iqbal
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Rex A. Cardan
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Richard A. Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Dennis N. Stanley
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Sui Shen
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Joel A. Pogue
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Xingen Wu
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Kevin Lee
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Samuel Marcrom
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Carlos E. Cardenas
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| |
Collapse
|
4
|
Pogue JA, Cardenas CE, Stanley DN, Stanley C, Hotsinpiller W, Veale C, Soike MH, Popple RA, Boggs DH, Harms J. Improved Dosimetry and Plan Quality for Accelerated Partial Breast Irradiation Using Online Adaptive Radiation Therapy: A Single Institutional Study. Adv Radiat Oncol 2024; 9:101414. [PMID: 38292886 PMCID: PMC10823088 DOI: 10.1016/j.adro.2023.101414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2023] [Accepted: 11/23/2023] [Indexed: 02/01/2024] Open
Abstract
Purpose Accelerated partial breast irradiation (APBI) is an attractive treatment modality for eligible patients as it has been shown to result in similar local control and improved cosmetic outcomes compared with whole breast radiation therapy. The use of online adaptive radiation therapy (OART) for APBI is promising as it allows for a reduction of planning target volume margins because breast motion and lumpectomy cavity volume changes are accounted for in daily imaging. Here we present a retrospective, single-institution evaluation on the adequacy of kV-cone beam computed tomography (CBCT) OART for APBI treatments. Methods and Materials Nineteen patients (21 treatment sites) were treated to 30 Gy in 5 fractions between January of 2022 and May of 2023. Time between simulation and treatment, change in gross tumor (ie, lumpectomy cavity) volume, and differences in dose volume histogram metrics with adaption were analyzed. The Wilcoxon paired, nonparametric test was used to test for dose volume histogram metric differences between the scheduled plans (initial plans recalculated on daily CBCT anatomy) and delivered plans, either the scheduled or adapted plan, which was reoptimized using daily anatomy. Results Median (interquartile range) time from simulation to first treatment was 26 days (21-32 days). During this same time, median gross tumor volume reduction was 16.0% (7.3%-23.9%) relative to simulation volume. Adaptive treatments took 31.3 minutes (27.4-36.6 minutes) from start of CBCT to treatment session end. At treatment, the adaptive plan was selected for 86% (89/103) of evaluable fractions. In evaluating plan quality, 78% of delivered plans met all target, organs at risk, and conformity metrics evaluated, compared with 34% of scheduled plans. Conclusions Use of OART for stereotactic linac-based APBI allowed for safe, high-quality treatments in this cohort of 21 treatment courses. Although treatment delivery times were longer than traditional stereotactic body treatments, there were notable improvements in plan quality for APBI using OART.
Collapse
Affiliation(s)
- Joel A. Pogue
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Carlos E. Cardenas
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Dennis N. Stanley
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Courtney Stanley
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Whitney Hotsinpiller
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Christopher Veale
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Michael H. Soike
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Richard A. Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Drexell H. Boggs
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Joseph Harms
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| |
Collapse
|
5
|
Stanley DN, Covington E, Harms J, Pogue J, Cardenas CE, Popple RA. Evaluation and correlation of patient movement during online adaptive radiotherapy with CBCT and a surface imaging system. J Appl Clin Med Phys 2023; 24:e14133. [PMID: 37643456 PMCID: PMC10691620 DOI: 10.1002/acm2.14133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Revised: 07/10/2023] [Accepted: 08/06/2023] [Indexed: 08/31/2023] Open
Abstract
PURPOSE With the clinical implementation of kV-CBCT-based daily online-adaptive radiotherapy, the ability to monitor, quantify, and correct patient movement during adaptive sessions is paramount. With sessions lasting between 20-45 min, the ability to detect and correct for small movements without restarting the entire session is critical to the adaptive workflow and dosimetric outcome. The purpose of this study was to quantify and evaluate the correlation of observed patient movement with machine logs and a surface imaging (SI) system during adaptive radiation therapy. METHODS Treatment machine logs and SGRT registration data log files for 1972 individual sessions were exported and analyzed. For each session, the calculated shifts from a pre-delivery position verification CBCT were extracted from the machine logs and compared to the SGRT registration data log files captured during motion monitoring. The SGRT calculated shifts were compared to the reported shifts of the machine logs for comparison for all patients and eight disease site categories. RESULTS The average (±STD) net displacement of the SGRT shifts were 2.6 ± 3.4 mm, 2.6 ± 3.5 mm, and 3.0 ± 3.2 in the lateral, longitudinal, and vertical directions, respectively. For the treatment machine logs, the average net displacements in the lateral, longitudinal, and vertical directions were 2.7 ± 3.7 mm, 2.6 ± 3.7 mm, and 3.2 ± 3.6 mm. The average difference (Machine-SGRT) was -0.1 ± 1.8 mm, 0.2 ± 2.1 mm, and -0.5 ± 2.5 mm for the lateral, longitudinal, and vertical directions. On average, a movement of 5.8 ± 5.6 mm and 5.3 ± 4.9 mm was calculated prior to delivery for the CBCT and SGRT systems, respectively. The Pearson correlation coefficient between CBCT and SGRT shifts was r = 0.88. The mean and median difference between the treatment machine logs and SGRT log files was less than 1 mm for all sites. CONCLUSION Surface imaging should be used to monitor and quantify patient movement during adaptive radiotherapy.
Collapse
Affiliation(s)
- Dennis N. Stanley
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Elizabeth Covington
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
- Department of Radiation OncologyMichigan MedicineAnn ArborMichiganUSA
| | - Joseph Harms
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Joel Pogue
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Carlos E. Cardenas
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Richard A. Popple
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| |
Collapse
|
6
|
Brown MH, Marcrom SR, Patel MP, Popple RA, Travis RL, McDonald AM, Riley KO, Markert JM, Willey CD, Bredel M, Fiveash JB, Thomas EM. Understanding the Effect of Prescription Isodose in Single-Fraction Stereotactic Radiosurgery on Plan Quality and Clinical Outcomes for Solid Brain Metastases. Neurosurgery 2023; 93:1313-1318. [PMID: 37449861 PMCID: PMC10627625 DOI: 10.1227/neu.0000000000002585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2022] [Accepted: 05/05/2023] [Indexed: 07/18/2023] Open
Abstract
BACKGROUND AND OBJECTIVES There is wide variation in treatment planning strategy for central nervous system (CNS) stereotactic radiosurgery. We sought to understand what relationships exist between intratumor maximum dose and local control (LC) or CNS toxicity, and dosimetric effects of constraining hotspots on plan quality of multiple metastases volumetric modulated arc therapy radiosurgery plans. METHODS We captured brain metastases from 2015 to 2017 treated with single-isocenter volumetric modulated arc therapy radiosurgery. Included tumors received single-fraction stereotactic radiosurgery, had no previous surgery or radiation, and available follow-up imaging. Our criterion for local failure was 25% increase in tumor diameter on follow-up MRI or pathologic confirmation of tumor recurrence. We defined significant CNS toxicity as Radiation Therapy Oncology Group irreversible Grade 3 or higher. We performed univariate and multivariate analyses evaluating factors affecting LC. We examined 10 stereotactic radiosurgery plans with prescriptions of 18 Gy to all targets originally planned without constraints on the maximum dose within the tumor. We replanned each with a constraint of Dmax 120%. We compared V50%, mean brain dose, and Dmax between plans. RESULTS Five hundred and thirty tumors in 116 patients were available for analysis. Median prescription dose was 18 Gy, and median prescription isodose line (IDL) was 73%. Kaplan-Meier estimate of 12-month LC only tumor volume (HR 1.43 [1.22-1.68] P < .001) was predictive of local failure on univariate analysis; prescription IDL and histology were not. In multivariate analysis, tumor volume impacted local failure (HR 1.43 [1.22-1.69] P < .001) but prescription IDL did not (HR 0.95 [0.86-1.05] P = .288). Only a single grade 3 and 2 grade 4 toxicities were observed; tumor volume was predictive of CNS toxicity (HR 1.58 [1.25-2.00]; P < .001), whereas prescription IDL was not (HR 1.01 [0.87-1.17] P = .940). CONCLUSION The prescription isodose line had no impact on local tumor control or CNS toxicity. Penalizing radiosurgery hotspots resulted in worse radiosurgery plans with poorer gradient. Limiting maximum dose in gross tumor causes increased collateral exposure to surrounding tissue and should be avoided.
Collapse
Affiliation(s)
- Matthew H. Brown
- Department of Radiation Oncology, University of Maryland, Baltimore, Maryland, USA
| | - Samuel R. Marcrom
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Mayank P. Patel
- Department of Radiation Oncology, University of Miami, Coral Gables, Florida, USA
| | - Richard A. Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Roman L. Travis
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Andrew M. McDonald
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Kristen O. Riley
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - James M. Markert
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Christopher D. Willey
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Markus Bredel
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - John B. Fiveash
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Evan M. Thomas
- Department of Radiation Oncology, Ohio State University, Columbus, Ohio, USA
| |
Collapse
|
7
|
Covington EL, Stanley DN, Sullivan RJ, Riley KO, Fiveash JB, Popple RA. Commissioning and clinical evaluation of the IDENTIFY TM surface imaging system for frameless stereotactic radiosurgery. J Appl Clin Med Phys 2023; 24:e14058. [PMID: 37289550 PMCID: PMC10562042 DOI: 10.1002/acm2.14058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2023] [Revised: 04/26/2023] [Accepted: 05/11/2023] [Indexed: 06/10/2023] Open
Abstract
PURPOSE To commission and assess the clinical performance of a new commercial surface imaging (SI) system by analyzing intra-fraction motion from the initial cohort of patients treated with frameless stereotactic radiosurgery (fSRS). METHODS The IDENTIFYTM SI system was commissioned for clinical use on an Edge (Varian Medical Systems, Palo Alto, CA) linear accelerator. All patients who received intracranial radiotherapy with HyperArcTM (Varian Medical Systems, Palo Alto, CA) were immobilized with the EncompassTM (Qfix, Avondale, PA) thermoplastic mask and monitored for intra-fraction motion with SI. IDENTIFYTM log files were correlated with trajectory log files to correlate treatment parameters with SI-reported offsets. IDENTIFYTM reported offsets were correlated with gantry and couch angles to assess system performance for obstructed and clear camera field of view. Data were stratified by race to evaluate performance differences due to skin tone. RESULTS All commissioning data were found to meet recommended tolerances. IDENTIFYTM was used to monitor intra-fraction motion on 1164 fractions from 386 patients. The median magnitude of translational SI reported offsets at the end of treatment was 0.27 mm. SI reported offsets were shown to increase when camera pods are blocked by the gantry with larger increases seen at non-zero couch angles. With camera obstruction, the median magnitude of the SI reported offset was 0.50 and 0.80 mm for White and Black patients, respectively. CONCLUSIONS IDENTIFYTM performance during fSRS is comparable to other commercially available SI systems where offsets are shown to increase at non-zero couch angles and during camera pod blockage.
Collapse
Affiliation(s)
- Elizabeth L. Covington
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
- Department of Radiation OncologyUniversity of MichiganAnn ArborMichiganUSA
| | - Dennis N. Stanley
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Rodney J. Sullivan
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Kristen O. Riley
- Department of NeurosurgeryUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - John B. Fiveash
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Richard A. Popple
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| |
Collapse
|
8
|
Pogue JA, Hotsinpiller WS, Cardenas C, Stanley C, Belliveau JG, Popple RA, Stanley DN, Boggs H, Harms J. kV-CBCT-Guided Daily Adaptation Improves Target Coverage and Spares Normal Tissue for Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 2023; 117:e706-e707. [PMID: 37786069 DOI: 10.1016/j.ijrobp.2023.06.2199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Linear accelerator based accelerated partial breast irradiation (APBI) in early-stage breast cancer necessitates a reduction in non-target breast tissue to decrease long term toxicity and adverse cosmetic outcome. In particular, lumpectomy cavity seromas may decrease in size and deform in shape during the course of short course APBI. Online adaptive RT (oART) offers considerable prospect for treating mobile targets through pendulous breast anatomy. However, there are limited studies outlining the methods and outcomes of CBCT-based oART for APBI. Here we present a retrospective, single institutional study analyzing the treatment process for patients receiving stereotactic kV-CBCT guided oART APBI. MATERIALS/METHODS Fourteen patients were treated to 30 Gy in 5 fractions for a total of 70 fractions. Time between simulation and treatment, change in gross tumor volume (GTV), and differences in DVH metrics with adaption were analyzed. The Wilcoxon paired, non-parametric test was utilized to test for DVH metric differences between the scheduled plans (initial plans recalculated on daily CBCT anatomy) and treated plans, which were either the scheduled or adapted plan (initial plans re-optimized using daily anatomy), depending on the preference of the treating physician or physicist. RESULTS Median (inter-quartile range) time from simulation to first treatment was 28 days (21-33 days). During this same time, GTV volume reduced to 72.5% (57.8-87.3%) of the simulation lumpectomy cavity volume. Adaptive treatments required 31.1 min (27.2-37.1 min) from start of CBCT to treatment session end. Table 1 summarizes differences between scheduled and treated plan metrics for 70 fractions, 62 (89%) of which were treated adaptively and 8 (11%) of which were treated using the scheduled plan. Significant improvement in prescription planning target volume coverage (p = 0.003), significant reduction in 5/6 organ-at-risk metrics evaluated (p ≤ 0.003), and significant improvement in conformity index and high dose spillage (p ≤ 0.001) were realized with adaption. Table 1: Scheduled versus treated plan metrics. CONCLUSION APBI using oART decreased most organs at risk DVH metrics, improved plan quality metrics, and increased target coverage, justifying the use of kV-CBCT-guided oART for APBI.
Collapse
Affiliation(s)
- J A Pogue
- University of Alabama at Birmingham, Birmingham, AL
| | | | - C Cardenas
- University of Alabama at Birmingham Department of Radiation Oncology, Birmingham, AL
| | - C Stanley
- University of Alabama at Birmingham, Birmingham, AL
| | | | - R A Popple
- University of Alabama at Birmingham, Birmingham, AL
| | - D N Stanley
- University of Alabama at Birmingham, Birmingham, AL
| | - H Boggs
- University of Alabama at Birmingham Department of Radiation Oncology, Birmingham, AL
| | - J Harms
- University of Alabama at Birmingham, Birmingham, AL
| |
Collapse
|
9
|
Ankrah NK, Thomas EM, Bredel M, Middlebrooks EH, Walker H, Fiveash JB, Guthrie BL, Popple RA, Roper J, Brinkerhoff S. Frameless LINAC-Based Stereotactic Radiosurgery is Safe and Effective for Essential and Parkinsonian Tremor. Int J Radiat Oncol Biol Phys 2023; 117:S173. [PMID: 37784432 DOI: 10.1016/j.ijrobp.2023.06.640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Stereotactic radiosurgery (SRS) to the thalamus is an ablative technique used for treatment of refractory tremor of essential or Parkinsonian origin. Because of the high dose, small target, and required precision, framed SRS on the Gamma Knife has been the historical platform of choice. We tested our recently developed technique to emulate GK dose distributions on a multi-leaf collimator (MLC)-equipped linear accelerator (LINAC) without cumbersome, inefficient cones in a prospective trial of safety and efficacy. MATERIALS/METHODS We quantified pre-treatment contralateral tremor according to FTM scoring system. We obtained MPRAGE, FGATIR, DTI, and RS-fMRI sequences. We identified the VIM via classical stereotactic reference location and connectomically, and then targeted it to 135 Gy dmax in a manner dosimetrically roughly equivalent to 4 mm GK shot. We adjusted each target such that the 25 Gy isodose line did not overlap the posterior limb of the capsule. We immobilized patients in a highly rigid thermoplastic mask and delivered treatment on an Edge™ LINAC with HDMLC. Intrafraction optical surface monitoring (OSMS) ensured patient immobility. We surveilled post-treatment imaging and recorded tremor scoring, QOL outcomes, and adverse events. RESULTS We accrued 42 patients (16 female, 26 males; median age 72.5) over 36 months. 38 had essential tremor, 4 had tremor-dominant Parkinson's; 2 withdrew prior to treatment. Ten patients were on therapeutic anti-coagulation, and were not required to discontinue. At time of submission 39 patients had follow-up ≥ 6 months. 35/39 (89.7%) exhibited clinically meaningful tremor reduction. Mean limb tremor reduction among responders was 43.5% (range: 9 - 100%). Time to patient-reported tremor improvement was 0.3 to 15 months. One patient experienced Gr 3, and 4 patients experienced Gr 1-2 toxicity. CONCLUSION MLC-based SRS thalamotomy is safe and effective for refractory tremor treatment. Multidisciplinary management is key for proper patient selection, treatment, and monitoring. Our outcomes appear congruent to historical GK controls as well as more modern MRgFUS outcomes.
Collapse
Affiliation(s)
- N K Ankrah
- University of Alabama Hospital Birmingham Alabama, Birmingham, AL
| | - E M Thomas
- Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH
| | - M Bredel
- University of Alabama at Birmingham Department of Radiation Oncology, Birmingham, AL
| | | | - H Walker
- University of Alabama at Birmingham, Birmingham, AL
| | - J B Fiveash
- University of Alabama at Birmingham Department of Radiation Oncology, Birmingham, AL
| | - B L Guthrie
- University of Alabama Hospital Birmingham, Birmingham, AL
| | - R A Popple
- University of Alabama at Birmingham, Birmingham, AL
| | - J Roper
- University of Auburn, Auburn, AL
| | - S Brinkerhoff
- University of Alabama Hospital Birmingham, Birmingham, AL
| |
Collapse
|
10
|
Mayo C, Feng M, Brock KK, Kudner RF, Balter P, Buchsbaum J, Caissie AL, Covington E, Daugherty EC, Fuller CD, Jr DSH, Krauze AV, Kruse JJ, McNutt TR, Popple RA, Richardson S, Palta JR, Purdie TG, Tarbox LR, Xiao Y. Operational Ontology for Radiation Oncology (OORO): A Professional Society-Based, Multi-Stakeholder Consensus Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data. Int J Radiat Oncol Biol Phys 2023; 117:S18-S19. [PMID: 37784446 DOI: 10.1016/j.ijrobp.2023.06.239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) There is a critical need for large-scale, multi-institutional "real-world" data to evaluate patient, diagnosis and treatment factors affecting oncology patient outcomes. However, lack of data standardization undermines the potential for automated learning from the vast amount of information routinely archived in electronic health records (EHRs), Radiation Oncology Information Systems and other cancer care databases. As next step to promote data standardization beyond the American Association of Physicists in Medicine (AAPM)'s TG-263 guidance for radiotherapy (RT) nomenclature, the AAPM's Big Data Subcommittee (BDSC) has led an international RT professional society collaboration to develop the Operational Ontology for Radiation Oncology (OORO). MATERIALS/METHODS Initiated July 2019 to explore issues that typically compromise formation of large inter- and intra- institutional databases from EHRs, the AAPM's BDSC membership includes representatives from the AAPM, American Society of Radiation Oncology (ASTRO), Canadian Organization of Medical Physicists (COMP), Canadian Association of Radiation Oncology (CARO), European Society of Therapeutic Radiation Oncology (ESTRO) and clinical trials experts from NRG Oncology. Multiple external stakeholders were engaged, including government agencies, vendors and RT community members through the iterative and consensus-driven approach to OORO development. RESULTS The OORO includes 42 key elements, 359 attributes, 144 value sets, and 155 relationships, ranked for priority of implementation based on clinical significance, likelihood of availability in EHRs, or ability to modify routine clinical processes to permit aggregation. The initial version of OORO includes many disease-site independent concepts common for all cancer patients and a smaller set specific for prostate cancer. The OORO development methodology is currently being applied/adapted to include additional disease site-specific concepts beginning with head and neck cancers. CONCLUSION The first of its kind in radiation oncology, the OORO is a professional society-based, multi-stakeholder, consensus driven informatics standard. The iterative and collaborative approach to ontology development and refinement aims to ensure that OORO serves as a « living » guidance document, facilitating incremental expansion of data elements over time, as disease site-specific standards are set and RT concepts evolve. Supporting construction of comprehensive "real-world" datasets and application of advanced analytic techniques, including artificial intelligence (AI), OORO holds the potential to revolutionize patient management and improve outcomes.
Collapse
Affiliation(s)
- C Mayo
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
| | - M Feng
- University of California, San Francisco, San Francisco, CA
| | - K K Brock
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - R F Kudner
- American Society for Radiation Oncology, Arlington, VA
| | - P Balter
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | | | - A L Caissie
- Dalhousie University/Nova Scotia Health, Halifax, NS, Canada
| | - E Covington
- University of Alabama at Birmingham, Birmingham, AL
| | - E C Daugherty
- Department of Radiation Oncology, University of Cincinnati Medical Center, Cincinnati, OH
| | - C D Fuller
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - D S Hong Jr
- Department of Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA
| | - A V Krauze
- National Institute of Health, Washington DC, DC
| | - J J Kruse
- Department of Radiation Oncology, Mayo Clinic, Rochester, MN
| | - T R McNutt
- Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
| | - R A Popple
- University of Alabama at Birmingham, Birmingham, AL
| | - S Richardson
- Washington University School of Medicine, Springfield, MO, United States
| | - J R Palta
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA
| | | | | | - Y Xiao
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA
| |
Collapse
|
11
|
Das IJ, Yadav P, Andersen AD, Chen ZJ, Huang L, Langer MP, Lee C, Li L, Popple RA, Rice RK, Schiff PB, Zhu TC, Abazeed ME. Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study. Radiother Oncol 2023; 182:109571. [PMID: 36822361 PMCID: PMC10121952 DOI: 10.1016/j.radonc.2023.109571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Revised: 02/07/2023] [Accepted: 02/12/2023] [Indexed: 02/23/2023]
Abstract
BACKGROUND AND PURPOSE Radiation dose prescriptions are foundational for optimizing treatment efficacy and limiting treatment-related toxicity. We sought to assess the lack of standardization of SBRT dose prescriptions across institutions. MATERIALS & METHODS Dosimetric data from 1298 patients from 9 academic institutions treated with IMRT and VMAT were collected. Dose parameters D100, D98, D95, D50, and D2 were used to assess dosimetric variability. RESULTS Disease sites included lung (48.3 %) followed by liver (29.7 %), prostate (7.5 %), spine (6.8 %), brain (4.1 %), and pancreas (2.5 %). The PTV volume in lung varied widely with bimodality into two main groups (22.0-28.7 cm3) and (48.0-67.1 cm3). A hot spot ranging from 120-150 % was noted in nearly half of the patients, with significant variation across institutions. A D50 ≥ 110 % was found in nearly half of the institutions. There was significant dosimetric variation across institutions. CONCLUSIONS The SBRT prescriptions in the literature or in treatment guidelines currently lack nuance and hence there is significant variation in dose prescriptions across academic institutions. These findings add greater importance to the identification of dose parameters associated with improved clinical outcome comparisons as we move towards more hypofractionated treatments. There is a need for standardized reporting to help institutions in adapting treatment protocols based on the outcome of clinical trials. Dosimetric parameters are subsequently needed for uniformity and thereby standardizing planning guidelines to maximize efficacy, mitigate toxicity, and reduce treatment disparities are urgently needed.
Collapse
Affiliation(s)
- Indra J Das
- Department of Radiation Oncology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
| | - Poonam Yadav
- Department of Radiation Oncology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Aaron D Andersen
- Department of Radiation Oncology, Renown Medical Center, Reno, NV, USA
| | - Zhe Jay Chen
- Department of Therapeutic Radiology, Yale University, New haven, CT, USA
| | - Long Huang
- Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA
| | - Mark P Langer
- Department of Radiation Oncology, Indiana University Health, Indianapolis, IN, USA
| | - Choonik Lee
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
| | - Lin Li
- Division of Biostatistics, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Roger K Rice
- Department of Radiation Medicine and Applied Science, University of California, San Diego, CA, USA
| | - Peter B Schiff
- Department of Radiation Oncology, New York University Grossman School of Medicine, New York, NY, USA
| | - Timothy C Zhu
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA
| | - Mohamed E Abazeed
- Department of Radiation Oncology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| |
Collapse
|
12
|
McDonald AM, Schneider CS, Stahl JM, Oster RA, Popple RA, Mayo CS. A focused review of statistical practices for relating radiation dose-volume exposure and toxicity. Radiat Oncol 2023; 18:57. [PMID: 36964622 PMCID: PMC10039562 DOI: 10.1186/s13014-023-02220-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Accepted: 01/31/2023] [Indexed: 03/26/2023] Open
Abstract
PURPOSE Relating dose-volume histogram (DVH) information to patient outcomes is critical for outcomes research in radiation oncology, but this is statistically challenging. We performed this focused review of DVH toxicity studies to characterize current statistical approaches and determine the need for updated reporting recommendations. METHODS AND MATERIALS We performed a focused MEDLINE search to identify studies published in 5 radiation oncology specialty journals that associated dosimetry with toxicity outcomes in humans receiving radiotherapy between 2015 and 2021. Elements abstracted from each manuscript included the study outcome, organs-at-risk (OARs) considered, DVH parameters analyzed, summary of the analytic approach, use of multivariable statistics, goodness-of-fit reporting, completeness of model reporting, assessment of multicollinearity, adjustment for multiple comparisons, and methods for dichotomizing variables. Each study was also assessed for sufficient reporting to allow for replication of results. RESULTS The MEDLINE search returned 2,300 studies for review and 325 met the inclusion criteria for the analysis. DVH variables were dichotomized using cut points in 154 (47.4%) studies. Logistic regression (55.4% of studies) was the most common statistical method used to relate DVH to toxicity outcomes, followed by Cox regression (20.6%) and linear regression (12.0%). Multivariable statistical tests were performed in 226 (69.5%) studies; of these, the possibility of multicollinearity was addressed in 47.8% and model goodness-of-fit were reported in 32.6%. The threshold for statistical significance was adjusted to account for multiple comparisons in 41 of 196 (17.1%) studies that included multiple statistical comparisons. Twenty-eight (8.6%) studies were classified as missing details necessary to reproduce the study results. CONCLUSIONS Current practices of statistical reporting in DVH outcomes suggest that studies may be vulnerable to threats against internal and external validity. Recommendations for reporting are provided herein to guard against such threats and to promote cohesiveness among radiation oncology outcomes researchers.
Collapse
Affiliation(s)
- Andrew M McDonald
- Department of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, Birmingham, AL, USA.
- Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA.
| | - Craig S Schneider
- Department of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, Birmingham, AL, USA
| | - John M Stahl
- Department of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Robert A Oster
- Department of Medicine, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, Hazelrig-Salter Radiation Oncology Center, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Charles S Mayo
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
| |
Collapse
|
13
|
Stanley DN, Harms J, Pogue JA, Belliveau JG, Marcrom SR, McDonald AM, Dobelbower MC, Boggs DH, Soike MH, Fiveash JA, Popple RA, Cardenas CE. A roadmap for implementation of kV-CBCT online adaptive radiation therapy and initial first year experiences. J Appl Clin Med Phys 2023:e13961. [PMID: 36920871 DOI: 10.1002/acm2.13961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2022] [Revised: 01/12/2023] [Accepted: 02/23/2023] [Indexed: 03/16/2023] Open
Abstract
PURPOSE Online Adaptive Radiation Therapy (oART) follows a different treatment paradigm than conventional radiotherapy, and because of this, the resources, implementation, and workflows needed are unique. The purpose of this report is to outline our institution's experience establishing, organizing, and implementing an oART program using the Ethos therapy system. METHODS We include resources used, operational models utilized, program creation timelines, and our institutional experiences with the implementation and operation of an oART program. Additionally, we provide a detailed summary of our first year's clinical experience where we delivered over 1000 daily adaptive fractions. For all treatments, the different stages of online adaption, primary patient set-up, initial kV-CBCT acquisition, contouring review and edit of influencer structures, target review and edits, plan evaluation and selection, Mobius3D 2nd check and adaptive QA, 2nd kV-CBCT for positional verification, treatment delivery, and patient leaving the room, were analyzed. RESULTS We retrospectively analyzed data from 97 patients treated from August 2021-August 2022. One thousand six hundred seventy seven individual fractions were treated and analyzed, 632(38%) were non-adaptive and 1045(62%) were adaptive. Seventy four of the 97 patients (76%) were treated with standard fractionation and 23 (24%) received stereotactic treatments. For the adaptive treatments, the generated adaptive plan was selected in 92% of treatments. On average(±std), adaptive sessions took 34.52 ± 11.42 min from start to finish. The entire adaptive process (from start of contour generation to verification CBCT), performed by the physicist (and physician on select days), was 19.84 ± 8.21 min. CONCLUSION We present our institution's experience commissioning an oART program using the Ethos therapy system. It took us 12 months from project inception to the treatment of our first patient and 12 months to treat 1000 adaptive fractions. Retrospective analysis of delivered fractions showed that the average overall treatment time was approximately 35 min and the average time for the adaptive component of treatment was approximately 20 min.
Collapse
Affiliation(s)
- Dennis N Stanley
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - Joseph Harms
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - Joel A Pogue
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - Jean-Guy Belliveau
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - Samuel R Marcrom
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - Andrew M McDonald
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - Michael C Dobelbower
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - Drexell H Boggs
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - Michael H Soike
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - John A Fiveash
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| | - Carlos E Cardenas
- Department of Radiation Oncology, University of Alabama, Birmingham, Alabama, USA
| |
Collapse
|
14
|
Pogue JA, Cardenas CE, Cao Y, Popple RA, Soike M, Boggs DH, Stanley DN, Harms J. Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning. Front Oncol 2023; 13:1130119. [PMID: 36845685 PMCID: PMC9950631 DOI: 10.3389/fonc.2023.1130119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2022] [Accepted: 02/02/2023] [Indexed: 02/12/2023] Open
Abstract
Background Accelerated partial breast irradiation (APBI) yields similar rates of recurrence and cosmetic outcomes as compared to whole breast radiation therapy (RT) when patients and treatment techniques are appropriately selected. APBI combined with stereotactic body radiation therapy (SBRT) is a promising technique for precisely delivering high levels of radiation while avoiding uninvolved breast tissue. Here we investigate the feasibility of automatically generating high quality APBI plans in the Ethos adaptive workspace with a specific emphasis on sparing the heart. Methods Nine patients (10 target volumes) were utilized to iteratively tune an Ethos APBI planning template for automatic plan generation. Twenty patients previously treated on a TrueBeam Edge accelerator were then automatically replanned using this template without manual intervention or reoptimization. The unbiased validation cohort Ethos plans were benchmarked via adherence to planning objectives, a comparison of DVH and quality indices against the clinical Edge plans, and qualitative reviews by two board-certified radiation oncologists. Results 85% (17/20) of automated validation cohort plans met all planning objectives; three plans did not achieve the contralateral lung V1.5Gy objective, but all other objectives were achieved. Compared to the Eclipse generated plans, the proposed Ethos template generated plans with greater evaluation planning target volume (PTV_Eval) V100% coverage (p = 0.01), significantly decreased heart V1.5Gy (p< 0.001), and increased contralateral breast V5Gy, skin D0.01cc, and RTOG conformity index (p = 0.03, p = 0.03, and p = 0.01, respectively). However, only the reduction in heart dose was significant after correcting for multiple testing. Physicist-selected plans were deemed clinically acceptable without modification for 75% and 90% of plans by physicians A and B, respectively. Physicians A and B scored at least one automatically generated plan as clinically acceptable for 100% and 95% of planning intents, respectively. Conclusions Standard left- and right-sided planning templates automatically generated APBI plans of comparable quality to manually generated plans treated on a stereotactic linear accelerator, with a significant reduction in heart dose compared to Eclipse generated plans. The methods presented in this work elucidate an approach for generating automated, cardiac-sparing APBI treatment plans for daily adaptive RT with high efficiency.
Collapse
Affiliation(s)
| | - Carlos E. Cardenas
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Yanan Cao
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Richard A. Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Michael Soike
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Drexell Hunter Boggs
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Dennis N. Stanley
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Joseph Harms
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States
| |
Collapse
|
15
|
Middlebrooks EH, Popple RA, Greco E, Okromelidze L, Walker HC, Lakhani DA, Anderson AR, Thomas EM, Deshpande HD, McCullough BA, Stover NP, Sung VW, Nicholas AP, Standaert DG, Yacoubian T, Dean MN, Roper JA, Grewal SS, Holland MT, Bentley JN, Guthrie BL, Bredel M. Connectomic Basis for Tremor Control in Stereotactic Radiosurgical Thalamotomy. AJNR Am J Neuroradiol 2023; 44:157-164. [PMID: 36702499 PMCID: PMC9891328 DOI: 10.3174/ajnr.a7778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Accepted: 12/30/2022] [Indexed: 01/27/2023]
Abstract
BACKGROUND AND PURPOSE Given the increased use of stereotactic radiosurgical thalamotomy and other ablative therapies for tremor, new biomarkers are needed to improve outcomes. Using resting-state fMRI and MR tractography, we hypothesized that a "connectome fingerprint" can predict tremor outcomes and potentially serve as a targeting biomarker for stereotactic radiosurgical thalamotomy. MATERIALS AND METHODS We evaluated 27 patients who underwent unilateral stereotactic radiosurgical thalamotomy for essential tremor or tremor-predominant Parkinson disease. Percentage postoperative improvement in the contralateral limb Fahn-Tolosa-Marin Clinical Tremor Rating Scale (TRS) was the primary end point. Connectome-style resting-state fMRI and MR tractography were performed before stereotactic radiosurgery. Using the final lesion volume as a seed, "connectivity fingerprints" representing ideal connectivity maps were generated as whole-brain R-maps using a voxelwise nonparametric Spearman correlation. A leave-one-out cross-validation was performed using the generated R-maps. RESULTS The mean improvement in the contralateral tremor score was 55.1% (SD, 38.9%) at a mean follow-up of 10.0 (SD, 5.0) months. Structural connectivity correlated with contralateral TRS improvement (r = 0.52; P = .006) and explained 27.0% of the variance in outcome. Functional connectivity correlated with contralateral TRS improvement (r = 0.50; P = .008) and explained 25.0% of the variance in outcome. Nodes most correlated with tremor improvement corresponded to areas of known network dysfunction in tremor, including the cerebello-thalamo-cortical pathway and the primary and extrastriate visual cortices. CONCLUSIONS Stereotactic radiosurgical targets with a distinct connectivity profile predict improvement in tremor after treatment. Such connectomic fingerprints show promise for developing patient-specific biomarkers to guide therapy with stereotactic radiosurgical thalamotomy.
Collapse
Affiliation(s)
- E H Middlebrooks
- From the Departments of Radiology (E.H.M., E.G., L.O., D.A.L.)
- Neurosurgery (E.H.M., S.S.G.), Mayo Clinic, Jacksonville, Florida
| | - R A Popple
- Departments of Radiation Oncology (R.A.P., A.R.A., E.M.T., M.B.)
| | - E Greco
- From the Departments of Radiology (E.H.M., E.G., L.O., D.A.L.)
| | - L Okromelidze
- From the Departments of Radiology (E.H.M., E.G., L.O., D.A.L.)
| | - H C Walker
- Neurology (H.C.W., B.A.M., N.P.S., V.W.S., A.P.N., D.G.S., T.Y., M.N.D.)
| | - D A Lakhani
- From the Departments of Radiology (E.H.M., E.G., L.O., D.A.L.)
- Department of Radiology (D.A.L.), West Virginia University, Morgantown, West Virginia
| | - A R Anderson
- Departments of Radiation Oncology (R.A.P., A.R.A., E.M.T., M.B.)
| | - E M Thomas
- Departments of Radiation Oncology (R.A.P., A.R.A., E.M.T., M.B.)
- Department of Radiation Oncology (E.M.T.), Ohio State University, Columbus, Ohio
| | | | - B A McCullough
- Neurology (H.C.W., B.A.M., N.P.S., V.W.S., A.P.N., D.G.S., T.Y., M.N.D.)
| | - N P Stover
- Neurology (H.C.W., B.A.M., N.P.S., V.W.S., A.P.N., D.G.S., T.Y., M.N.D.)
| | - V W Sung
- Neurology (H.C.W., B.A.M., N.P.S., V.W.S., A.P.N., D.G.S., T.Y., M.N.D.)
| | - A P Nicholas
- Neurology (H.C.W., B.A.M., N.P.S., V.W.S., A.P.N., D.G.S., T.Y., M.N.D.)
| | - D G Standaert
- Neurology (H.C.W., B.A.M., N.P.S., V.W.S., A.P.N., D.G.S., T.Y., M.N.D.)
| | - T Yacoubian
- Neurology (H.C.W., B.A.M., N.P.S., V.W.S., A.P.N., D.G.S., T.Y., M.N.D.)
| | - M N Dean
- Neurology (H.C.W., B.A.M., N.P.S., V.W.S., A.P.N., D.G.S., T.Y., M.N.D.)
| | - J A Roper
- School of Kinesiology (J.A.R.), Auburn University, Auburn, Alabama
| | - S S Grewal
- Neurosurgery (E.H.M., S.S.G.), Mayo Clinic, Jacksonville, Florida
| | - M T Holland
- Neurosurgery (M.T.H., J.N.B., B.L.G.), University of Alabama at Birmingham, Birmingham, Alabama
| | - J N Bentley
- Neurosurgery (M.T.H., J.N.B., B.L.G.), University of Alabama at Birmingham, Birmingham, Alabama
| | - B L Guthrie
- Neurosurgery (M.T.H., J.N.B., B.L.G.), University of Alabama at Birmingham, Birmingham, Alabama
| | - M Bredel
- Departments of Radiation Oncology (R.A.P., A.R.A., E.M.T., M.B.)
| |
Collapse
|
16
|
Zhao X, Stanley DN, Cardenas CE, Harms J, Popple RA. Do we need patient-specific QA for adaptively generated plans? Retrospective evaluation of delivered online adaptive treatment plans on Varian Ethos. J Appl Clin Med Phys 2022; 24:e13876. [PMID: 36560887 PMCID: PMC9924122 DOI: 10.1002/acm2.13876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2022] [Revised: 11/09/2022] [Accepted: 11/15/2022] [Indexed: 12/24/2022] Open
Abstract
BACKGROUND The clinical introduction of dedicated treatment units for online adaptive radiation therapy (OART) has led to widespread adoption of daily adaptive radiotherapy. OART allows for rapid generation of treatment plans using daily patient anatomy, potentially leading to reduction of treatment margins and increased normal tissue sparing. However, the OART workflow does not allow for measurement of patient-specific quality assurance (PSQA) during treatment delivery sessions and instead relies on secondary dose calculations for verification of adapted plans. It remains unknown if independent dose verification is a sufficient surrogate for PSQA measurements. PURPOSE To evaluate the plan quality of previously treated adaptive plans through multiple standard PSQA measurements. METHODS This IRB-approved retrospective study included sixteen patients previously treated with OART at our institution. PSQA measurements were performed for each patient's scheduled and adaptive plans: five adaptive plans were randomly selected to perform ion chamber measurements and two adaptive plans were randomly selected for ArcCHECK measurements. The same ArcCHECK 3D dose distribution was also sent to Mobius3D to evaluate the second-check dosimetry system. RESULTS All (n = 96) ion chamber measurements agreed with the planned dose within 3% with a mean of 1.4% (± 0.7%). All (n = 48) plans passed ArcCHECK measurements using a 95% gamma passing threshold and 3%/2 mm criteria with a mean of 99.1% (± 0.7%). All (n = 48) plans passed Mobius3D second-check performed with 95% gamma passing threshold and 5%/3 mm criteria with a mean of 99.0% (± 0.2%). CONCLUSION Plan measurement for PSQA may not be necessary for every online-adaptive treatment verification. We recommend the establishment of a periodic PSQA check to better understand trends in passing rates for delivered adaptive treatments.
Collapse
Affiliation(s)
- Xiaodong Zhao
- Department of Radiation OncologyWashington University in St. LouisSt. LouisMissouriUSA
| | - Dennis N. Stanley
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Carlos E. Cardenas
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Joseph Harms
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Richard A. Popple
- Department of Radiation OncologyUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| |
Collapse
|
17
|
Zhao X, Covington EL, Popple RA. Analysis of a surface imaging system using a six degree-of-freedom couch. J Appl Clin Med Phys 2022; 23:e13697. [PMID: 35819973 PMCID: PMC9359042 DOI: 10.1002/acm2.13697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Revised: 03/31/2022] [Accepted: 05/19/2022] [Indexed: 11/29/2022] Open
Abstract
Purpose To validate surface imaging (SI)‐reported offsets using a six degree‐of‐freedom couch and an anthropomorphic phantom for commissioning and routine quality assurance of an SI system used for stereotactic radiosurgery (SRS). Methods An anthropomorphic phantom with a radiopaque ball bearing (BB) placed either anterior, midline, or posterior, was tracked with SI with a typical SRS region of interest. Couch motion in all six degrees of freedom was programmed and delivered on a linac. SI system logs were synchronized with linac trajectory logs. Ten random couch positions were selected at couch 0°, 45°, 90°, 270°, 315° with megavolt (MV) images taken to account for couch walkout. The SI residual error (ε), the difference between SI reported offset and MV or trajectory log position, was calculated. Residual errors were measured with and without one SI pod blocked. Results The median [range] of magnitude of translational ε was 0.13 [0.07, 0.21], 0.16 [0.11, 0.26], 0.61 [0.50, 0.68], 0.49 [0.42, 0.55], 0.55 [0.38, 0.72] mm for couch rotations of 0°, 45°, 90°, 270°, 315°, respectively, for the midline BB and no pod blocked. The range of all translational ε from all couch angles (with and without pod block) at different BB positions is [0.05, 0.96] mm. The absolute range of difference when changing BB position when no pod is blocked in median translational ε is [0.01, 0.40] mm with the maximum at BB posterior. The absolute range of difference when not changing BB positions with and without pod block in median translational ε is [0.01, 0.37] mm with the maximum at BB posterior and couch 315°. Conclusion SI system and linac trajectory log analysis can be used to assess SI system performance with automated couch motion to validate SI accuracy.
Collapse
Affiliation(s)
- Xiaodong Zhao
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Elizabeth L Covington
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| |
Collapse
|
18
|
Brown TAD, Ayers RG, Popple RA. Commissioning a multileaf collimator virtual cone for the stereotactic radiosurgery of trigeminal neuralgia. J Appl Clin Med Phys 2022; 23:e13562. [PMID: 35157356 PMCID: PMC9121036 DOI: 10.1002/acm2.13562] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 12/15/2021] [Accepted: 02/02/2022] [Indexed: 11/13/2022] Open
Abstract
A multileaf collimator (MLC), virtual‐cone treatment technique has been commissioned for trigeminal neuralgia (TGN) at Tri‐Cities Cancer Center (TCCC). This novel technique was initially developed at the University of Alabama in Birmingham (UAB); it is designed to produce a spherical dose profile similar to a fixed, 5‐mm conical collimator distribution. Treatment is delivered with a 10‐MV flattening‐filter‐free (FFF) beam using a high‐definition MLC on a Varian Edge linear accelerator. Absolute dose output and profile measurements were performed in a 20 × 20 × 14 cm3 solid‐water phantom using an Exradin W2 scintillation detector and Gafchromic EBT3 film. Dose output constancy for the virtual cone was evaluated over 6 months using an Exradin A11 parallel plate chamber. The photo‐neutron dose generated by these treatments was assessed at distances of 50 and 100 cm from isocenter using a Ludlum Model 30–7 Series Neutron Meter. TGN treatments at TCCC have been previously delivered at 6‐MV FFF using a 5‐mm stereotactic cone. To assess the dosimetric impact of using a virtual cone, eight patients previously treated for TGN with a 5‐mm cone were re‐planned using a virtual cone. Seven patients have now been treated for TGN using a virtual cone at TCCC. Patient‐specific quality assurance was performed for each patient using Gafchromic EBT‐XD film inside a Standard Imaging Stereotactic Dose Verification Phantom. The commissioning results demonstrate that the virtual‐cone dosimetry, first described at UAB, is reproducible on a second Edge linear accelerator at an independent clinical site. The virtual cone is a credible alternative to a physical, stereotactic cone for the treatment of TGN at TCCC.
Collapse
Affiliation(s)
| | - Rex G Ayers
- Northwest Medical Physics Center, Lynnwood, Washington, USA
| | - Richard A Popple
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA
| |
Collapse
|
19
|
Moradi LA, Schneider CS, Deshane AS, Popple RA, Kim RY, Marcrom SR. Hypofractionated radiation leads to more rapid bleeding cessation in women with vaginal bleeding secondary to gynecologic malignancy. Radiat Oncol 2022; 17:34. [PMID: 35164826 PMCID: PMC8842901 DOI: 10.1186/s13014-022-01995-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Accepted: 01/19/2022] [Indexed: 01/21/2023] Open
Abstract
Background Vaginal bleeding (VB) is common in women with gynecologic (GYN) malignancies. Radiation therapy (RT) is used for the definitive treatment of GYN cancers and palliation of bleeding. The historical dogma is that high dose-per-fraction radiation leads to more rapid bleeding cessation, yet there is scant data supporting this claim. We sought to examine the effect of RT fraction size on VB via retrospective analysis of patients receiving hypofractionated radiation (HFRT) compared to conventionally fractionated radiation (CFRT) for control of bleeding secondary to GYN malignancies. Methods We identified patients receiving external beam RT for continuous VB from GYN malignancy treated in our department from 2012 to 2020. RT was classified as HFRT (> 2.0 Gy/fx) or CFRT (1.8–2.0 Gy/fx). Demographic information, disease characteristics, and treatment details were collected. The primary endpoint was days from RT initiation until bleeding resolution. Characteristics between groups were compared via Fisher’s exact test. Time to bleeding cessation was assessed via Kaplan–Meier and log-rank test. Univariable and multivariable Cox-proportional hazards were used to identify factors associated with bleeding cessation. Results We identified 43 patients meeting inclusion criteria with 26 and 17 patients receiving CFRT and HFRT, respectively. Comparison of baseline characteristics revealed patients receiving HFRT were older (p = 0.001), more likely to be post-menopausal (p = 0.002), and less likely to receive concurrent chemotherapy (p = 0.004). Time to bleeding cessation was significantly shorter for patients receiving HFRT (log-rank p < 0.001) with median time to bleeding cessation of 5 days (HFRT) versus 16 days (CFRT). Stratification by dose-per-fraction revealed a dose–response effect with more rapid bleeding cessation with increased dose-per-fraction. While HFRT, age, recurrent disease, prior pelvic RT, and prior systemic therapy were associated with time to bleeding cessation on univariable analysis, HFRT was the only factor significantly associated with time to bleeding cessation in the final multivariable model (HR 3.26, p = 0.008). Conclusions Patients with continuous VB from GYN tumors receiving HFRT experienced more rapid bleeding cessation than those receiving CFRT. For patients with severe VB, initiation of HFRT to control malignancy related bleeding quickly may be warranted. Supplementary Information The online version contains supplementary material available at 10.1186/s13014-022-01995-7.
Collapse
|
20
|
Popple RA, Sullivan RJ, Yuan Y, Wu X, Covington EL. Evaluation of a two-dimensional diode array for patient-specific quality assurance of HyperArc. J Appl Clin Med Phys 2021; 22:203-210. [PMID: 34725909 PMCID: PMC8664143 DOI: 10.1002/acm2.13438] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2021] [Revised: 08/31/2021] [Accepted: 09/04/2021] [Indexed: 11/06/2022] Open
Abstract
PURPOSE To evaluate a two-dimensional diode array for patient-specific quality assurance of VMAT stereotactic radiosurgery (SRS) plans. METHODS The diode array, an SRS MapCHECK (SRSMC), was composed of a 77 mm ×77 mm face-centered array having a spacing of 2.47 mm. Sixty SRS plans were selected from our clinical database, 30 for treatment of a single target and 30 for multiple targets. The target sizes ranged from 2.4 mm to 44.7 mm equivalent diameter (median 8.7 mm). The plans were delivered to the diode array. For multiple target plans, two measurements were obtained at two locations, one corresponding to the largest target and the other to the smallest target. Gamma using a 3%/1 mm criteria and the dose to the center diode were compared with radiochromic film (RCF). Dose to selected regions of the detector electronics was calculated. RESULTS The mean difference between the center diode and RCF was -1.2%. For a threshold of at least 95% of detectors/pixels having gamma < 1 for a 3%/1 mm criteria, SRSMC and RCF gave consistent results for 79 of the 90 measurements. For plans with an arc having a patient support angle of 90° or 270°, the median dose to the electronics was 0.65% of the prescription dose. CONCLUSIONS SRSMC is an efficient tool for accurate patient-specific quality assurance of VMAT single and multiple target radiosurgery, yielding similar clinical decisions as radiochromic film.
Collapse
Affiliation(s)
- Richard A Popple
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Rodney J Sullivan
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Yuan Yuan
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Xingen Wu
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Elizabeth L Covington
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA
| |
Collapse
|
21
|
Cardan RA, Covington EL, Popple RA. Code Wisely: Risk assessment and mitigation for custom clinical software. J Appl Clin Med Phys 2021; 22:273-279. [PMID: 34247454 PMCID: PMC8364260 DOI: 10.1002/acm2.13348] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Revised: 05/18/2021] [Accepted: 06/07/2021] [Indexed: 12/02/2022] Open
Abstract
Purpose The task of software development has become an increasing part of the medical physicist's role. Many physicists who are untrained in the best practices of software development have begun creating scripts for clinical use. There is an increasing need for guidance for both developers and medical physicists to code wisely in the clinic. Materials and Methods We created a novel model for assessing risk for custom clinical software analogous to failure modes and effects analysis and propose minimum best practices that should be followed to mitigate the risks. Using this risk model, we integrated a literature review and institutional experience to form a practical guide for risk mitigation. Results Using this new risk assessment model, we outlined several risk mitigation techniques including unit testing, code review, source control, end‐user testing, and commissioning from the literature while sharing our institutional guidelines for evaluating software for risk and implementing these strategies. Conclusion We found very little literature for custom software development guidelines targeted at medical physicists. We have shared our institutional experience and guidelines to help facilitate safe software development for the evolving role of the medical physicist.
Collapse
Affiliation(s)
- Rex A Cardan
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Elizabeth L Covington
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| |
Collapse
|
22
|
Abstract
A procedure is presented to assess performance at non-zero couch angles and perform routine quality assurance (QA) on surface-guided radiotherapy (SGRT) imaging systems used for stereotactic radiosurgery (SRS). A low-cost anthropomorphic phantom was used to assess the system under patient-like conditions. The phantom is embedded with a tungsten ball bearing (BB) to facilitate the use of surface imaging (SI) with concurrent megavoltage (MV) imaging to cross-compare and validate SI-reported offsets. Data analysis is done via in-house software that utilized the SGRT system’s log files for automated analysis. This procedure enables users to assess and inter-compare MV-reported offsets with their SGRT system. The analysis provides SGRT system residual error so that users are aware of inherent offsets present in addition to increases in translational offsets due to couch walkout. The procedure was validated with two commercial SGRT systems. The procedure can be used with any surface imaging system and linear accelerator system.
Collapse
Affiliation(s)
| | - Richard A Popple
- Radiation Oncology, University of Alabama at Birmingham, Birmingham, USA
| |
Collapse
|
23
|
Popple RA, Brown MH, Thomas EM, Willey CD, Cardan RA, Covington EL, Riley KO, Markert JM, Bredel M, Fiveash JB. Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance Results. Pract Radiat Oncol 2021; 11:e163-e171. [PMID: 33632630 DOI: 10.1016/j.prro.2020.10.013] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2020] [Revised: 09/24/2020] [Accepted: 10/21/2020] [Indexed: 10/22/2022]
Abstract
PURPOSE Properly planned single isocenter volumetric modulated arc therapy (VMAT) radiosurgery plans exhibit high quality and efficiency. We report here the largest clinical experience to date, to our knowledge, comparing manual planning with a new automated platform designed to standardize and simplify radiosurgery planning and delivery processes. METHODS We treated 693 patients with single isocenter VMAT radiosurgical plans generated by either our conventional manual (mVMAT) or a recently implemented automated (HyperArcTM) technique. All plans targeted the gross tumor volume without margin. Radiochromic film was used for patient-specific quality assurance (PSQA). We evaluated local control and toxicity data for a subgroup of 107 patients having 377 metastatic tumors that were treated with HyperArc. RESULTS The median Radiation Therapy Oncology Group (RTOG) conformity index was 1.14 and was not different between the 2 techniques. The median Paddick gradient index was 5.42 for HyperArc versus 7.09 for mVMAT (P < .001). The median mean brain doses were 4.6% and 5.1% for HyperArc and mVMAT, respectively (P = .04). The PSQA for both techniques met clinical criteria, but 97% of the HyperArc plans satisfied the gamma tolerance limit recommended by the American Association of Physicists in Medicine Task Group No. 218, compared with 94% of the mVMAT plans (P = .02). The median treatment-planning times were not significantly different. The median treatment times were 10.5 and 11.4 minutes for HyperArc and mVMAT, respectively (P < .001). The Kaplan-Meier estimate of local control was 90.1% at 1 year. CONCLUSIONS HyperArc produces high-quality radiosurgical plans that are at least as good as mVMAT plans created by an expert manual planner with easier planning and more efficient delivery workflow. A less experienced planner can produce very high-quality radiosurgical plans even for patients with more than 10 targets. The use of a single-isocenter technique for multiple targets with no PTV margin did not compromise clinical outcomes, and 1-year local control for treated targets remained congruent with historical series.
Collapse
Affiliation(s)
- Richard A Popple
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama.
| | - Matthew H Brown
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Evan M Thomas
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Christopher D Willey
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Rex A Cardan
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Elizabeth L Covington
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Kristen O Riley
- Department of Neurosurgery, The University of Alabama at Birmingham, Birmingham, Alabama
| | - James M Markert
- Department of Neurosurgery, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Markus Bredel
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - John B Fiveash
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| |
Collapse
|
24
|
Stanley DN, Covington EL, Liu H, Alexandrian AN, Cardan RA, Bridges DS, Thomas EM, Fiveash JB, Popple RA. Accuracy of dose-volume metric calculation for small-volume radiosurgery targets. Med Phys 2021; 48:1461-1468. [PMID: 33294990 PMCID: PMC8248418 DOI: 10.1002/mp.14645] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2020] [Revised: 11/18/2020] [Accepted: 11/26/2020] [Indexed: 11/10/2022] Open
Abstract
PURPOSE For stereotactic radiosurgery (SRS), accurate evaluation of dose-volume metrics for small structures is necessary. The purpose of this study was to compare the DVH metric capabilities of five commercially available SRS DVH analysis tools (Eclipse, Elements, Raystation, MIM, and Velocity). METHODS DICOM RTdose and RTstructure set files created using MATLAB were imported and evaluated in each of the tools. Each structure set consisted of 50 randomly placed spherical targets. The dose distributions were created on a 1-mm grid using an analytic model such that the dose-volume metrics of the spheres were known. Structure sets were created for 3, 5, 7, 10, 15, and 20 mm diameter spheres. The reported structure volume, V100% [cc], and V50% [cc], and the RTOG conformity index and Paddick Gradient Index, were compared with the analytical values. RESULTS The average difference and range across all evaluated target sizes for the reported structure volume was - 4.73%[-33.2,0.2], 0.11%[-10.9, 9.5], -0.39%[-12.1, 7.0], -2.24%[-21.0, 1.3], and 1.15%[-15.1,0.8], for TPS-A through TPS-E, respectively. The average difference and range for the V100%[cc] (V20Gy[cc]) was - 0.4[-24.5,9.8], -2.73[-23.6, 1.1], -3.01[-23.6, 0.6], -3.79[-27.3, 1.3], and 0.26[-6.1,2.6] for TPS-A through TPS-E, respectively. For V50%[cc](V10Gy[cc]) in TPS-A through TPS-E the average and ranger were - 0.05[-0.8,0.4], -0.18[-1.2, 0.5], -0.44[-1.4, 0.3], -0.26[-1.8, 2.6], and 0.09[-1.4,2.7]. CONCLUSION This study expanded on the previously published literature to quantitatively compare the DVH analysis capabilities of software commonly used for SRS plan evaluation and provides freely available and downloadable analytically derived set of ground truth DICOM dose and structure files for the use of radiotherapy clinics. The differences between systems highlight the need for standardization and/or transparency between systems, especially when evaluating plan quality for multi-institutional clinical trials.
Collapse
Affiliation(s)
- Dennis N Stanley
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Elizabeth L Covington
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Haisong Liu
- Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA
| | - Ara N Alexandrian
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.,Department of Radiation Oncology, University of Washington, Seattle, WA, USA
| | - Rex A Cardan
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Daniel S Bridges
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Evan M Thomas
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - John B Fiveash
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| |
Collapse
|
25
|
Covington EL, Stanley DN, Fiveash JB, Thomas EM, Marcrom SR, Bredel M, Willey CD, Riley KO, Popple RA. Surface guided imaging during stereotactic radiosurgery with automated delivery. J Appl Clin Med Phys 2020; 21:90-95. [PMID: 33095971 PMCID: PMC7769383 DOI: 10.1002/acm2.13066] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2020] [Revised: 07/29/2020] [Accepted: 09/22/2020] [Indexed: 01/31/2023] Open
Abstract
PURPOSE To report on the use of surface guided imaging during frameless intracranial stereotactic radiotherapy with automated delivery via HyperArcTM (Varian Medical Systems, Palo Alto, CA). METHODS All patients received intracranial radiotherapy with HyperArcTM and were monitored for intrafraction motion by the AlignRT® (VisionRT, London, UK) surface imaging (SI) system. Immobilization was with the EncompassTM (Qfix, Avondale, PA) aquaplast mask device. AlignRT® log files were correlated with trajectory log files to correlate treatment parameters with SI reported offsets. SI reported offsets were correlated with gantry angle and analyzed for performance issues at non-zero couch angles and during camera-pod blockage during gantry motion. Demographics in the treatment management system were used to identify race and determine if differences in SI reported offsets are due to skin tone settings. RESULTS A total of 981 fractions were monitored over 14 months and 819 were analyzed. The median AlignRT® reported motion from beginning to the end of treatment was 0.24 mm. The median offset before beam on at non-zero couch angles was 0.55 mm. During gantry motion when camera pods are blocked, the median magnitude was below 1 mm. Median magnitude of offsets at non-zero couch angles was not found to be significantly different for patients stratified by race. CONCLUSIONS Surface image guidance is a viable alternative to scheduled mid-treatment imaging for monitoring intrafraction motion during stereotactic radiosurgery with automated delivery.
Collapse
Affiliation(s)
- Elizabeth L Covington
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| | - Dennis N Stanley
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| | - John B Fiveash
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| | - Evan M Thomas
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| | - Samuel R Marcrom
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| | - Marcus Bredel
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| | - Christopher D Willey
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| | - Kristen O Riley
- Department of Neurosurgery, University of Alabama - Birmingham, Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| |
Collapse
|
26
|
Snyder JD, Sullivan RJ, Wu X, Covington EL, Popple RA. Use of a plastic scintillator detector for patient-specific quality assurance of VMAT SRS. J Appl Clin Med Phys 2020; 20:143-148. [PMID: 31538717 PMCID: PMC6753731 DOI: 10.1002/acm2.12705] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2019] [Revised: 07/13/2019] [Accepted: 07/25/2019] [Indexed: 11/30/2022] Open
Abstract
Purpose To evaluate a scintillator detector for patient‐specific quality assurance of VMAT radiosurgery plans. Methods The detector was comprised of a 1 mm diameter, 1 mm high scintillator coupled to an acrylic optical fiber. Sixty VMAT SRS plans for treatment of single targets having sizes ranging from 3 mm to 30.2 mm equivalent diameter (median 16.3 mm) were selected. The plans were delivered to a 20 cm × 20 cm x 15 cm water equivalent plastic phantom having either the scintillator detector or radiochromic film at the center. Calibration films were obtained for each measurement session. The films were scanned and converted to dose using a 3‐channel technique. Results The mean difference between scintillator and film was ‒0.45% (95% confidence interval ‒0.1% to 0.8%). For target equivalent diameter smaller than the median, the mean difference was 1.1% (95% confidence interval 0.5% to 1.7%). For targets larger than the median, the mean difference was ‒0.2% (95% confidence interval ‒0.7% to 0.1%). Conclusions The scintillator detector response is independent of target size for targets as small as 3 mm and is well‐suited for patient‐specific quality assurance of VMAT SRS plans. Further work is needed to evaluate the accuracy for VMAT plans that treat multiple targets using a single isocenter.
Collapse
Affiliation(s)
- Jesse D Snyder
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA
| | - Rodney J Sullivan
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA
| | - Xingen Wu
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA
| | - Elizabeth L Covington
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA
| |
Collapse
|
27
|
Covington EL, Popple RA, Cardan RA. Technical Note: Use of automation to eliminate shift errors. J Appl Clin Med Phys 2020; 21:192-195. [PMID: 32039543 PMCID: PMC7075372 DOI: 10.1002/acm2.12830] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2019] [Revised: 12/19/2019] [Accepted: 01/11/2020] [Indexed: 11/24/2022] Open
Abstract
Purpose To create automated tools within the treatment planning system (TPS) that eliminate the common error pathway of providing incorrect shift instructions to therapists. Materials/Methods Two scripts were created within the TPS using the Eclipse API (Varian Medical Systems, Palo Alto, CA). One script detects whether or not the user origin has been placed correctly at the intersection of the simulation markers while the other calculates a shift instruction sheet that can be printed for treatment. Results Analysis of our RO‐ILS database identified eight errors caused by improper setting of the user origin in the treatment planning system. The user origin script flagged all of the treatment plans for markers inconsistent with user origin. Automated calculation of shifts eliminated the error pathway of miscalculating or transcribing shift values. Conclusion Automation can eliminate the common error pathway of providing the wrong shifts to therapists. The scripts have been made available as open‐source software for implementation at other radiotherapy clinics.
Collapse
Affiliation(s)
- Elizabeth L Covington
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| | - Rex A Cardan
- Department of Radiation Oncology, University of Alabama - Birmingham, Birmingham, AL, USA
| |
Collapse
|
28
|
Dobelbower MC, Popple RA, Minnich DJ, Nader DA, Zimmerman F, Paris GE, Herth FJ, Gompelmann D, Roeder FF, Parikh PJ, McDonald AM. Anchored Transponder Guided Lung Radiation Therapy. Pract Radiat Oncol 2020; 10:e37-e44. [DOI: 10.1016/j.prro.2019.08.009] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2019] [Revised: 07/30/2019] [Accepted: 08/07/2019] [Indexed: 10/26/2022]
|
29
|
Liu H, Thomas EM, Li J, Yu Y, Andrews D, Markert JM, Fiveash JB, Shi W, Popple RA. Interinstitutional Plan Quality Assessment of 2 Linac-Based, Single-Isocenter, Multiple Metastasis Radiosurgery Techniques. Adv Radiat Oncol 2019; 5:1051-1060. [PMID: 33089021 PMCID: PMC7560574 DOI: 10.1016/j.adro.2019.10.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2019] [Accepted: 10/28/2019] [Indexed: 12/05/2022] Open
Abstract
Purpose Interest and application of stereotactic radiosurgery for multiple brain metastases continue to increase. Various planning systems are available for linear accelerator (linac)–based single-isocenter multiple metastasis radiosurgery. Two of the most advanced systems are BrainLAB Multiple Metastases Elements (MME), a dynamic conformal arc (DCA) approach, and Varian RapidArc (RA), a volumetric modulated arc therapy (VMAT) approach. In this work, we systematically compared plan quality between the 2 techniques. Methods and Materials Thirty patients with 4 to 10 metastases (217 total; median 7.5; Vmin = 0.014 cm3; Vmax = 17.73 cm3) were planned with both Varian RA and MME at 2 different institutions with extensive experience in each respective technique. All plans had a single isocenter and used Varian linac equipped with high-definition multileaf collimator. RA plans used 2 to 4 noncoplanar VMAT arcs with 10 MV flattening filter-free beam. MME plans used 4 to 9 noncoplanar DCAs and 6 MV flattening filter-free beam, (minimum planning target volume [PTVmin] = 0.49 cm3; PTVmax = 27.32 cm3; PTVmedian = 7.05 cm3). Prescriptions were 14 to 24 Gy in a single fraction. Target coverage goal was 99% of volume receiving prescription dose (D99% ≥ 100%). Plans were evaluated by Radiation Therapy Oncology Group/Paddick conformity index (CI) score, 12 Gy volume (V12Gy), V8Gy, V5Gy, mean brain dose (Dmean), and beam-on time. Results Conformity was favorable among RA plans (median: MME CIRTOG = 1.38; RA CIRTOG = 1.21; P < .0001). V12Gy and V8Gy were lower for RA plans (median: MME V12 = 23.7 cm3; RA V12 = 19.2 cm3; P = .0001; median: MME V8Gy = 53.6 cm3; RA V8Gy = 44.1 cm3; P = .024). V5Gy was lower for MME plans (median: MME V5Gy = 141.4 cm3; RA V5Gy = 142.8 cm3; P = .009). Mean brain was lower for MME plans (median: MME Dmean = 2.57 Gy; RA Dmean = 2.76 Gy; P < .0001). Conclusions For linac-based multiple metastasis stereotactic radiosurgery, RapidArc VMAT facilitates favorable conformity and V12Gy/V8Gy volume compared with the MME DCA plan. MME planning facilitates reduced dose spill at levels ≤V5Gy.
Collapse
Affiliation(s)
- Haisong Liu
- Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania
| | - Evan M Thomas
- Department of Radiation Oncology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama
| | - Jun Li
- Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania
| | - Yan Yu
- Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania
| | - David Andrews
- Department of Neurosurgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania
| | - James M Markert
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama
| | - John B Fiveash
- Department of Radiation Oncology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama
| | - Wenyin Shi
- Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama
| |
Collapse
|
30
|
Cardan RA, Covington EL, Popple RA. Technical Note: An open source solution for improving TG-263 compliance. J Appl Clin Med Phys 2019; 20:163-165. [PMID: 31536666 PMCID: PMC6753723 DOI: 10.1002/acm2.12701] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2019] [Revised: 08/01/2019] [Accepted: 08/02/2019] [Indexed: 11/08/2022] Open
Abstract
PURPOSE Compliance with TG-263 nomenclature standards can be challenging. We introduce an open source solution to this problem and evaluate its impact on compliance within our institution. MATERIALS/METHODS The TG-236 nomenclature standards were implemented in our clinic in two phases. In phase 1, we deployed TG-263 compliant templates for each disease site. In phase 2, we developed and deployed a script for evaluating compliance which presented errors to the user. After each phase the compliance was recorded. RESULTS Mean compliance errors prior to phase 1 was 31.8% ± 17.4%. Error rates dropped to 8.1% ± 12.2% across phase 1 and dropped further to 2.2% ± 6.9% during the automation system deployed in phase 2. CONCLUSION Both structure templates and automation scripts are very useful for increasing compliance with structure naming standards. Our software solution is made available on GitHub for other institutions to implement.
Collapse
Affiliation(s)
- Rex A Cardan
- Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, AL, USA
| | - Elizabeth L Covington
- Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, AL, USA
| |
Collapse
|
31
|
Marcrom SR, Foreman PM, Colvin TB, McDonald AM, Kirkland RS, Popple RA, Riley KO, Markert JM, Willey CD, Bredel M, Fiveash JB. Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease. Adv Radiat Oncol 2019; 5:34-42. [PMID: 32051888 PMCID: PMC7004932 DOI: 10.1016/j.adro.2019.07.016] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2019] [Revised: 07/10/2019] [Accepted: 07/12/2019] [Indexed: 12/30/2022] Open
Abstract
Purpose Surgery is often used for large or symptomatic brain metastases but is associated with risk of developing leptomeningeal dissemination. Emerging data suggest that fractionated stereotactic radiation therapy (FSRT) is an effective management strategy in large brain metastases. We sought to retrospectively compare leptomeningeal disease (LMD) and local control (LC) rates for patients treated with surgical resection followed by radiosurgery (S + SRS) versus FSRT alone. Methods and Materials We identified all patients with a brain metastasis ≥3 cm in diameter treated from 2004 to 2017 with S + SRS or FSRT alone (25 or 30 Gy in 5 fractions) who had follow-up imaging. LMD was defined as focal or diffuse leptomeningeal enhancement that was >5 mm from the index metastasis. Categorical baseline characteristics were compared with the χ2 test. LMD and LC rates were evaluated by the Kaplan-Meier (KM) method, with the log-rank test used to compare subgroups. Results A total of 125 patients were identified, including 82 and 43 in the S + SRS and FSRT alone groups, respectively. Median pretreatment Graded Prognostic Assessment in the S + SRS and FSRT groups was 2.5 and 1.5, respectively (P < .001). Median follow-up was 7 months. The KM estimate of 12-month LMD rate in the S + SRS and FSRT groups was 45% and 19%, respectively (P = .048). The KM estimate of 12-month local control in the S + SRS and FSRT groups was 70% and 69%, respectively (P = .753). The 12-month KM estimate of grade ≥3 toxicity was 1.4% in S + SRS group versus 6.3% in the FSRT alone group (P = .248). After adjusting for graded prognostic assessment (GPA), no overall survival difference was observed between groups (P = .257). Conclusions Surgery is appropriate for certain brain metastases, but S + SRS may increase LMD risk compared with FSRT alone. Because S + SRS and FSRT seem to have similar LC, FSRT may be a viable alternative to S + SRS in select patients with large brain metastases.
Collapse
Affiliation(s)
- Samuel R Marcrom
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Paul M Foreman
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama
| | - Tyler B Colvin
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Andrew M McDonald
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Robert S Kirkland
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Kristen O Riley
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama
| | - James M Markert
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama
| | - Christopher D Willey
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Markus Bredel
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - John B Fiveash
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| |
Collapse
|
32
|
Cardan RA, Covington EL, Fiveash JB, Popple RA. Using a whiteboard web application for tracking treatment workflow metrics for dosimetrists and physicians. Med Dosim 2019; 45:73-76. [PMID: 31371240 DOI: 10.1016/j.meddos.2019.07.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2019] [Revised: 05/10/2019] [Accepted: 07/01/2019] [Indexed: 01/07/2023]
Abstract
We present a framework for collecting data which elucidates detailed clinical flow timelines for different treatment sites, modalities, planners, and physicians in radiotherapy treatments. A web based tool, the Whiteboard, was developed which allows communication between the physicians and staff about the current state of the radiotherapy treatment plan and provides detailed time data for each stage of the patient's journey from simulation to treatment. Detailed timestamped data was collected over a period of 6 years which included 22 discrete steps of the treatment planning process. Whiteboard data was combined with data in the treatment planning database Aria (Varian Medical Systems, Palo Alto, CA) using the Eclipse Scripting API to include treatment plan information. Over 6 years, 110,477 patient statuses were time-logged for 9683 courses of treatment using our Whiteboard software, which allowed determination of patient volumes per individual and the time to perform planning tasks. The mean planning volume per dosimetrist was 375.8 ± 142.4 plans and 71.03 ± 27.10 plan revisions per year. The mean planning volume per physician was 218.9 ± 110.8 plan approvals with 41.55 ± 43.73 plan revisions per year. Physician contour time was a mean of 79.59 ± 84.61 hours, but varied greatly by diagnosis category and physician. The longest median modality planning time of 119.6 hours was for the IMRT plans with 8 or more fields. The shortest median times were 48.25, 49.53, and 50.98 hours for plans with 5, 4, and 3 fields, respectively. We demonstrated a framework that could help facilities in staff planning and aid in workload distribution, and could be used to improve understanding of radiotherapy timelines for patients, payers, and other institutions involved in radiotherapy processes.
Collapse
Affiliation(s)
- Rex A Cardan
- Department of Radiation Oncology, University of Alabama, Birmingham, AL 35249, USA
| | | | - John B Fiveash
- Department of Radiation Oncology, University of Alabama, Birmingham, AL 35249, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama, Birmingham, AL 35249, USA
| |
Collapse
|
33
|
McDonald AM, Galgano SJ, McConathy JE, Yang ES, Dobelbower MC, Jacob R, Rais-Bahrami S, Nix JW, Popple RA, Fiveash JB. Feasibility of Dose Escalating [ 18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer. Adv Radiat Oncol 2019; 4:649-658. [PMID: 31673658 PMCID: PMC6817530 DOI: 10.1016/j.adro.2019.05.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2019] [Revised: 05/22/2019] [Accepted: 05/24/2019] [Indexed: 02/03/2023] Open
Abstract
Purpose The aim of this study was to report the treatment planning feasibility of dose escalation to suspicious lymph nodes (LNs) for a series of men who underwent pretreatment [18F]fluciclovine positron emission tomography (PET)/magnetic resonance imaging (MRI). Methods and Materials Cases of men with prostate cancer who enrolled in a clinical trial of pretreatment [18F]fluciclovine PET who had suspicious LNs were selected. Pelvic LNs <1 cm were defined as positive based on [18F]fluciclovine-PET if their maximum standardized uptake value (SUVmax) was ≥1.3-fold greater than the reference blood pool SUVmean, and LNs ≥1 cm were defined as positive if the SUV was greater than the reference SUV bone marrow reference. For each case, a radiation treatment plan was generated to deliver 70 Gy to the prostate and proximal seminal vesicles, 60.2 Gy to the PET-positive LNs, and 50.4 Gy to the elective nodal regions, simultaneously in 28 fractions of 2.5 Gy, 2.15 Gy, and 1.8 Gy, respectively. Treatment planning goals were defined a priori. The resulting target volume and organ-at-risk dosimetry were compared with the original treatment plan. Results Four cases were identified, with between 1 and 5 [18F]fluciclovine PET–positive LNs each. Goals for the prostate and elective nodal target volumes were successfully met in all cases. The goal of covering more than 90% of the positive LN planning target volume by the prescription dose of 60.2 Gy was met in 3 of the 4 cases. This goal was not met in 1 case, but 100% of clinical target volume was covered by 60.2 Gy. The primary organ-at-risk tradeoff was that a small volume (0.5-8.2 cm3) of small bowel would receive ≥54 Gy in each case. Conclusions These preliminary results suggest that [18F]fluciclovine PET/MRI directed dose escalation of suspicious pelvic LNs is likely feasible in the setting of definitive radiation therapy. The potential clinical benefit of dose escalating [18F]fluciclovine PET–positive LNs should be investigated in a prospective clinical trial.
Collapse
Affiliation(s)
- Andrew M. McDonald
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
- Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama
- Corresponding author.
| | - Samuel J. Galgano
- Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama
| | | | - Eddy S. Yang
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
- Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama
| | - Michael C. Dobelbower
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
- Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama
| | - Rojymon Jacob
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
- Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama
| | - Soroush Rais-Bahrami
- Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama
- Department of Urology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Jeffrey W. Nix
- Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama
- Department of Urology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Richard A. Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - John B. Fiveash
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
- Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama
| |
Collapse
|
34
|
Covington EL, Fiveash JB, Wu X, Brezovich I, Willey CD, Riley K, Popple RA. Optical surface guidance for submillimeter monitoring of patient position during frameless stereotactic radiotherapy. J Appl Clin Med Phys 2019; 20:91-98. [PMID: 31095866 PMCID: PMC6560239 DOI: 10.1002/acm2.12611] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2018] [Revised: 04/10/2019] [Accepted: 04/18/2019] [Indexed: 11/12/2022] Open
Abstract
PURPOSE To evaluate the accuracy of monitoring intrafraction motion during stereotactic radiotherapy with the optical surface monitoring system. Prior studies showing a false increase in the magnitude of translational offsets at non-coplanar couch positions prompted the vendor to implement software changes. This study evaluated two software improvements intended to address false offsets. METHODS The vendor implemented two software improvements: a volumetric (ACO) rather than planar calibration and, approximately 6 months later, an improved calibration workflow (CIB) designed to better compensate for thermal drift. Offsets relative to the reference position, obtained at table angle 0 following image-guided setup, were recorded before beam-on at each table position and at the end of treatment the table returned to 0° for patients receiving SRT. RESULTS Prior to ACO, between ACO and CIB, and after CIB, 223, 155, and 436 fractions were observed respectively. The median magnitude of translational offsets at the end of treatment was similar for all three intervals: 0.29, 0.33, and 0.27 mm. Prior to ACO, the offset magnitude for non-zero table positions had a median of 0.79 mm and was found to increase with increasing distance from isocenter to the anterior patient surface. After ACO, the median magnitude was 0.74 mm, but the dependence on surface-to-isocenter distance was eliminated. After CIB, the median magnitude for non-zero table positions was reduced to 0.57 mm. CONCLUSION Ongoing improvements in software and calibration procedures have decreased reporting of false offsets at non-zero table angles. However, the median magnitude for non-zero table angles is larger than that observed at the end of treatment, indicating that accuracy remains better when the table is not rotated.
Collapse
Affiliation(s)
- Elizabeth L Covington
- Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, AL, USA
| | - John B Fiveash
- Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, AL, USA
| | - Xingen Wu
- Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, AL, USA
| | - Ivan Brezovich
- Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, AL, USA
| | - Christopher D Willey
- Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, AL, USA
| | - Kristen Riley
- Department of Neurosurgery, University of Alabama-Birmingham, Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, AL, USA
| |
Collapse
|
35
|
Brezovich IA, Wu X, Popple RA, Covington E, Cardan R, Shen S, Fiveash J, Bredel M, Guthrie B. Stereotactic radiosurgery with MLC-defined arcs: Verification of dosimetry, spatial accuracy, and end-to-end tests. J Appl Clin Med Phys 2019; 20:84-98. [PMID: 30977297 PMCID: PMC6522994 DOI: 10.1002/acm2.12583] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2017] [Revised: 01/25/2019] [Accepted: 03/05/2019] [Indexed: 12/14/2022] Open
Abstract
Purpose To measure dosimetric and spatial accuracy of stereotactic radiosurgery (SRS) delivered to targets as small as the trigeminal nerve (TN) using a standard external beam treatment planning system (TPS) and multileaf collimator‐(MLC) equipped linear accelerator without cones or other special attachments or modifications. Methods Dosimetric performance was assessed by comparing computed dose distributions to film measurements. Comparisons included the γ‐index, beam profiles, isodose lines, maximum dose, and spatial accuracy. Initially, single static 360° arcs of MLC‐shaped fields ranging from 1.6 × 5 to 30 × 30 mm2 were planned and delivered to an in‐house built block phantom having approximate dimensions of a human head. The phantom was equipped with markings that allowed accurate setup using planar kV images. Couch walkout during multiple‐arc treatments was investigated by tracking a ball pointer, initially positioned at cone beam computed tomography (CBCT) isocenter, as the couch was rotated. Tracks were mapped with no load and a 90 kg stack of plastic plates simulating patient treatment. The dosimetric effect of walkout was assessed computationally by comparing test plans that corrected for walkout to plans that neglected walkout. The plans involved nine 160° arcs of 2.4 × 5 mm2 fields applied at six different couch angles. For end‐to‐end tests that included CT simulation, target contouring, planning, and delivery, a cylindrical phantom mimicking a 3 mm lesion was constructed and irradiated with the nine‐arc regimen. The phantom, lacking markings as setup aids was positioned under CBCT guidance by registering its surface and internal structures with CTs from simulation. Radiochromic film passing through the target center was inserted parallel to the coronal and the sagittal plane for assessment of spatial and dosimetric accuracy. Results In the single‐arc block phantom tests computed maximum doses of all field sizes agreed with measurements within 2.4 ± 2.0%. Profile widths at 50% maximum agreed within 0.2 mm. The largest targeting error was 0.33 mm. The γ‐index (3%, 1 mm) averaged over 10 experiments was >1 in only 1% of pixels for field sizes up to 10 × 10 mm2 and rose to 4.4% as field size increased to 20 × 20 mm2. Table walkout was not affected by load. Walkout shifted the target up to 0.6 mm from CBCT isocenter but, according to computations shifted the dose cloud of the nine‐arc plan by only 0.16 mm. Film measurements verified the small dosimetric effect of walkout, allowing walkout to be neglected during planning and treatment. In the end‐to‐end tests average and maximum targeting errors were 0.30 ± 0.10 and 0.43 mm, respectively. Gamma analysis of coronal and sagittal dose distributions based on a 3%/0.3 mm agreement remained <1 at all pixels. To date, more than 50 functional SRS treatments using MLC‐shaped static field arcs have been delivered. Conclusion Stereotactic radiosurgery (SRS) can be planned and delivered on a standard linac without cones or other modifications with better than 0.5 mm spatial and 5% dosimetric accuracy.
Collapse
Affiliation(s)
- Ivan A Brezovich
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Xingen Wu
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Elizabeth Covington
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Rex Cardan
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Sui Shen
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - John Fiveash
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Markus Bredel
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Barton Guthrie
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA
| |
Collapse
|
36
|
Covington EL, Snyder JD, Wu X, Cardan RA, Popple RA. Assessing the feasibility of single target radiosurgery quality assurance with portal dosimetry. J Appl Clin Med Phys 2019; 20:135-140. [PMID: 30933414 PMCID: PMC6522988 DOI: 10.1002/acm2.12578] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2018] [Revised: 12/19/2018] [Accepted: 03/11/2019] [Indexed: 12/31/2022] Open
Abstract
Purpose To assess the feasibility of using portal dosimetry (PD) for pre‐treatment quality assurance of single target, flattening filter free (FFF), volumetric arc therapy intracranial radiosurgery plans. Methods A PD algorithm was created for a 10X FFF beam on a Varian Edge linear accelerator (Varian Inc, Palo Alto, CA, USA). Treatment plans that were previously evaluated with Gafchromic EBT‐XD (Ashland, Bridgewater, NJ, USA) film were measured via PD and analyzed with the ARIA Portal Dosimetry workspace. Absolute dose evaluation for film and PD was done by computing the mean dose in the region receiving greater than or equal to 90% of the max dose and comparing to the mean dose in the same region calculated by the treatment planning system (TPS). Gamma analysis with 10% threshold and 3%/2 mm passing criteria was performed on film and portal images. Results Thirty‐six PD verification plans were delivered and analyzed. The average PD to TPS dose was 0.989 ± 0.01 while film to TPS dose was 1.026 ± 0.01. All PD plans passed the gamma analysis with 100% of points having gamma <1. Overall, PD to TPS dose agreement was found to be target size dependent. As target size decreases, PD to TPS dose ratio decreased from 1.004 for targets with diameters between 15–31 mm and 0.978 for targets with diameters less than 15 mm. Conclusion The agreement of PD to TPS mean dose in the high dose region was found to be dependent on target size. Film measurements did not exhibit size dependence. All PD plans passed the 3%/2 mm gamma analysis, but caution should be used when using PD to assess overall dosimetric accuracy of the treatment plan for small targets.
Collapse
Affiliation(s)
- Elizabeth L Covington
- Department of Radiation Oncology, University of Alabama - Birmingham, South Birmingham, AL, USA
| | - Jesse D Snyder
- Department of Radiation Oncology, University of Alabama - Birmingham, South Birmingham, AL, USA
| | - Xingen Wu
- Department of Radiation Oncology, University of Alabama - Birmingham, South Birmingham, AL, USA
| | - Rex A Cardan
- Department of Radiation Oncology, University of Alabama - Birmingham, South Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama - Birmingham, South Birmingham, AL, USA
| |
Collapse
|
37
|
McDonald AM, Colvin T, Boggs DH, Spencer SA, Popple RA, Clayton R, Minnich D, Dobelbower MC. Longitudinal assessment of anchored transponder migration following lung stereotactic body radiation therapy. J Appl Clin Med Phys 2018; 20:17-22. [PMID: 30387242 PMCID: PMC6333116 DOI: 10.1002/acm2.12454] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2018] [Revised: 06/26/2018] [Accepted: 08/04/2018] [Indexed: 11/10/2022] Open
Abstract
Purpose To assess the long‐term stability of the anchored radiofrequency transponders and compare displacement rates with other commercially available lung fiducial markers. We also sought to describe late toxicity attributable to fiducial implantation or migration. Materials and methods The transponder cohort was comprised of 17 patients at our institution who enrolled in a multisite prospective clinical trial and underwent bronchoscopic implantation of three anchored transponders into small (2–2.5 mm) airways. We generated a comparison cohort of 34 patients by selecting patients from our institutional lung SBRT database and matching 2:1 based on the lobe containing tumor and proximity to the bronchial tree. Assessment of migration was performed by rigidly registering the most recent follow‐up CT scan to the simulation scan, and assessing whether the relative geometry of the fiducial markers had changed by more than 5 mm. Toxicity outcomes of interest were hemoptysis and pneumothorax. Results The median follow‐up of patients in the transponder cohort was 25.3 months and the median follow‐up in the comparison cohort was 21.7 months. When assessing the most recent CT, all fiducial markers were within 5 mm of their position at CT simulation in 11 (65%) patients in the transponder group as compared to 23 (68%) in the comparison group (P = 0.28). One case of hemoptysis was identified in the transponder cohort, and bronchoscopy confirmed bleeding from recurrent tumor; no cases of hemoptysis were noted in the comparison cohort. No case of pneumothorax was noted in either group. Conclusion No significant difference in the rates of fiducial marker retention and migration were noted when comparing patients who had anchored transponders placed into small airways and a 2:1 matched cohort of patients who had other commercially available lung fiducial markers placed. In both groups, no late or chronic toxicity appeared to be related to the implanted fiducial markers.
Collapse
Affiliation(s)
- Andrew M McDonald
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Tyler Colvin
- University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
| | - D Hunter Boggs
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Sharon A Spencer
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Ravinder Clayton
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Douglas Minnich
- Grandview Medical Center, Thoracic Surgery, Birmingham, AL, USA
| | - Michael C Dobelbower
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
| |
Collapse
|
38
|
Popple RA, Wu X, Brezovich IA, Markert JM, Guthrie BL, Thomas EM, Bredel M, Fiveash JB. The virtual cone: A novel technique to generate spherical dose distributions using a multileaf collimator and standardized control-point sequence for small target radiation surgery. Adv Radiat Oncol 2018; 3:421-430. [PMID: 30197943 PMCID: PMC6127970 DOI: 10.1016/j.adro.2018.02.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2017] [Revised: 01/09/2018] [Accepted: 02/21/2018] [Indexed: 02/05/2023] Open
Abstract
Purpose The study aimed to develop and demonstrate a standardized linear accelerator multileaf collimator-based method of delivering small, spherical dose distributions suitable for radiosurgical treatment of small targets such as the trigeminal nerve. Methods and materials The virtual cone is composed of a multileaf collimator–defined field with the central 2 leaves set to a small gap. For 5 table positions, clockwise and counter-clockwise arcs were used with collimator angles of 45 and 135 degrees, respectively. The dose per degree was proportional to the sine of the gantry angle. The dose distribution was calculated by the treatment planning system and measured using radiochromic film in a skull phantom for leaf gaps of 1.6, 2.1, and 2.6 mm. Cones with a diameter of 4 mm and 5 mm were measured for comparison. Output factor constancy was investigated using a parallel-plate chamber. Results The mean ratio of the measured-to-calculated dose was 0.99, 1.03, and 1.05 for 1.6, 2.1, and 2.6 mm leaf gaps, respectively. The diameter of the measured (calculated) 50% isodose line was 4.9 (4.6) mm, 5.2 (5.1) mm, and 5.5 (5.5) mm for the 1.6, 2.1, and 2.6 mm leaf gap, respectively. The measured diameter of the 50% isodose line was 4.5 and 5.7 mm for the 4 mm and 5 mm cones, respectively. The standard deviation of the parallel-plate chamber signal relative to a 10 cm × 10 cm field was less than 0.4%. The relative signal changed 32% per millimeter change in leaf gap, indicating that the parallel-plate chamber is sensitive to changes in gap width. Conclusions The virtual cone is an efficient technique for treatment of small spherical targets. Patient-specific quality assurance measurements will not be necessary in routine clinical use. Integration directly into the treatment planning system will make planning using this technique extremely efficient.
Collapse
Affiliation(s)
- Richard A Popple
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Xingen Wu
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Ivan A Brezovich
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - James M Markert
- Department of Neurosurgery, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Barton L Guthrie
- Department of Neurosurgery, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Evan M Thomas
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - Markus Bredel
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| | - John B Fiveash
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama
| |
Collapse
|
39
|
Yuan Y, Thomas EM, Clark GA, Markert JM, Fiveash JB, Popple RA. Evaluation of multiple factors affecting normal brain dose in single-isocenter multiple target radiosurgery. J Radiosurg SBRT 2018; 5:131-144. [PMID: 29657894 PMCID: PMC5893454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/04/2017] [Accepted: 09/18/2017] [Indexed: 06/08/2023]
Abstract
We investigated the effects of multiple planning factors on normal brain dose for single-isocenter VMAT stereotactic radiosurgery (SRS). Ten patients were retrospectively planned using a standardized objective function and all 16 combinations of 2 versus 4 arcs, collimator angle 45° versus selected per beam to minimize area of normal brain exposed in the beams-eye-view, fixed jaw versus following the trailing MLC leaf, and a 2 Gy mean dose objective for healthy brain versus no low dose objective. Limiting the normal brain mean dose in the optimization objective function significantly reduced the low dose spill into the normal brain without changing target coverage. Jaw tracking and appropriate selection of collimator also reduced the low dose volume, but to a lesser extent. To reduce low dose spill into normal brain for single isocenter VMAT radiosurgery of multiple targets, it is important to incorporate a limit on low dose spill into the objective function. This study has implications beyond single-isocenter VMAT radiosurgery. When comparing different inverse-planned treatment techniques, metrics that are important for evaluation of plan quality must be included the objective function.
Collapse
Affiliation(s)
- Yu Yuan
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
| | - Evan M. Thomas
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
| | - Grant A. Clark
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
| | - James M. Markert
- Department of Neurosurgery, The University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - John B. Fiveash
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
| | - Richard A. Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
| |
Collapse
|
40
|
Marcrom SR, McDonald AM, Thompson JW, Popple RA, Riley KO, Markert JM, Willey CD, Bredel M, Fiveash JB. Fractionated stereotactic radiation therapy for intact brain metastases. Adv Radiat Oncol 2017; 2:564-571. [PMID: 29204523 PMCID: PMC5707424 DOI: 10.1016/j.adro.2017.07.006] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2017] [Revised: 06/12/2017] [Accepted: 07/14/2017] [Indexed: 11/06/2022] Open
Abstract
Purpose Limited data exist on fractionated stereotactic radiation therapy (FSRT) for brain metastases. We sought to evaluate the safety and efficacy of FSRT and further define its role in brain metastasis management. Methods and materials A total of 72 patients were treated with linear accelerator–based FSRT to 182 previously untreated, intact brain metastases. Targets received 25 or 30 Gy in 5 fractions. All targets within the same course received the same prescription regardless of size. Toxicity was recorded per Radiation Therapy Oncology Group central nervous system toxicity criteria. Results The median follow-up was 5 months (range, 1-71 months). The Kaplan-Meier estimate of 12-month local control was 86%. Tumors <3 cm in diameter demonstrated improved 12-month local control of 95% compared with 61% in tumors ≥3 cm (P < .001). The Kaplan-Meier estimate of 12-month local control was 91% in tumors treated with 30 Gy and only 75% in tumors treated with 25 Gy (P = .015). Tumor diameter ≥3 cm resulted in increased local failure, and a 30 Gy prescription resulted in decreased local failure on multivariate analysis (hazard ratio [HR], 8.11 [range, 2.09-31.50; P = .003] and HR, 0.26 [range, 0.07-0.93; P = .038]). Grade 4 central nervous system toxicity occurred in 4 patients (6%) requiring surgery, and no patient experienced irreversible grade 3 or 5 toxicity. Increasing tumor diameter was associated with increased toxicity risk (HR, 2.45 [range, 1.04-5.742; P = .04]). Conclusions FSRT for brain metastases appears to demonstrate a high rate of local control with minimal risk of severe toxicity. Local control appears to be associated with smaller tumor sizeand a higher prescription dose. FSRT is a viable option for those who are poor single-fraction candidates.
Collapse
Affiliation(s)
- Samuel R Marcrom
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Andrew M McDonald
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Jonathan W Thompson
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Kristen O Riley
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama
| | - James M Markert
- Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama
| | - Christopher D Willey
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Markus Bredel
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| | - John B Fiveash
- Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama
| |
Collapse
|
41
|
Cardan RA, Popple RA, Fiveash J. A priori patient-specific collision avoidance in radiotherapy using consumer grade depth cameras. Med Phys 2017; 44:3430-3436. [PMID: 28474757 DOI: 10.1002/mp.12313] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2017] [Revised: 04/25/2017] [Accepted: 04/25/2017] [Indexed: 11/06/2022] Open
Abstract
PURPOSE In this study, we demonstrate and evaluate a low cost, fast, and accurate avoidance framework for radiotherapy treatments. Furthermore, we provide an implementation which is patient specific and can be implemented during the normal simulation process. METHODS Four patients and a treatment unit were scanned with a set of consumer depth cameras to create a polygon mesh of each object. Using a fast polygon interference algorithm, the models were virtually collided to map out feasible treatment positions of the couch and gantry. The actual physical collision space was then mapped in the treatment room by moving the gantry and couch until a collision occurred with either the patient or hardware. The physical and virtual collision spaces were then compared to determine the accuracy of the system. To improve the collision predictions, a buffer geometry was added to the scanned gantry mesh and performance was assessed as a function of buffer thickness. RESULTS Each patient was optically scanned during simulation in less than 1 min. The average time to virtually map the collision space for 64, 800 gantry/couch states was 5.40 ± 2.88 s. The system had an average raw accuracy and negative prediction rate (NPR) across all patients of 97.3% ± 2.4% and 96.9% ± 2.2% respectively. Using a polygon buffer of 6 cm over the gantry geometry, the NPR was raised to unity for all patients, signifying the detection of all collision events. However, the average accuracy fell from 95.3% ± 3.1% to 91.5% ± 3.6% between the 3 and 6 cm buffer as more false positives were detected. CONCLUSIONS We successfully demonstrated a fast and low cost framework which can map an entire collision space a priori for a given patient during the time of simulation. All collisions can be avoided using polygon interference, but a polygon buffer may be required to account for geometric uncertainties of scanned objects.
Collapse
Affiliation(s)
- Rex A Cardan
- Department of Radiation Oncology, University of Alabama at Birmingham, 2145 Bonner Way, Birmingham, AL, 35243, USA
| | - Richard A Popple
- Department of Radiation Oncology, University of Alabama at Birmingham, 1700 6th Ave S, Birmingham, AL, 35233, USA
| | - John Fiveash
- Department of Radiation Oncology, University of Alabama at Birmingham, 1700 6th Ave S, Birmingham, AL, 35233, USA
| |
Collapse
|
42
|
Brezovich IA, Popple RA, Duan J, Shen S, Wu X, Benhabib S, Huang M, Cardan RA. A novel phantom and procedure providing submillimeter accuracy in daily QA tests of accelerators used for stereotactic radiosurgery*. J Appl Clin Med Phys 2016; 17:246-253. [PMID: 27455506 PMCID: PMC5690062 DOI: 10.1120/jacmp.v17i4.6295] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2016] [Revised: 03/17/2016] [Accepted: 03/15/2016] [Indexed: 12/01/2022] Open
Abstract
Stereotactic radiosurgery (SRS) places great demands on spatial accuracy. Steel BBs used as markers in quality assurance (QA) phantoms are clearly visible in MV and planar kV images, but artifacts compromise cone‐beam CT (CBCT) isocenter localization. The purpose of this work was to develop a QA phantom for measuring with sub‐mm accuracy isocenter congruence of planar kV, MV, and CBCT imaging systems and to design a practical QA procedure that includes daily Winston‐Lutz (WL) tests and does not require computer aid. The salient feature of the phantom (Universal Alignment Ball (UAB)) is a novel marker for precisely localizing isocenters of CBCT, planar kV, and MV beams. It consists of a 25.4 mm diameter sphere of polymethylmetacrylate (PMMA) containing a concentric 6.35 mm diameter tungsten carbide ball. The large density difference between PMMA and the polystyrene foam in which the PMMA sphere is embedded yields a sharp image of the sphere for accurate CBCT registration. The tungsten carbide ball serves in finding isocenter in planar kV and MV images and in doing WL tests. With the aid of the UAB, CBCT isocenter was located within 0.10±0.05 mm of its true positon, and MV isocenter was pinpointed in planar images to within 0.06±0.04 mm. In clinical morning QA tests extending over an 18 months period the UAB consistently yielded measurements with sub‐mm accuracy. The average distance between isocenter defined by orthogonal kV images and CBCT measured 0.16±0.12 mm. In WL tests the central ray of anterior beams defined by a 1.5×1.5 cm2 MLC field agreed with CBCT isocenter within 0.03±0.14 mm in the lateral direction and within 0.10±0.19 mm in the longitudinal direction. Lateral MV beams approached CBCT isocenter within 0.00±0.11 mm in the vertical direction and within ‐0.14±0.15 mm longitudinally. It took therapists about 10 min to do the tests. The novel QA phantom allows pinpointing CBCT and MV isocenter positions to better than 0.2 mm, using visual image registration. Under CBCT guidance, MLC‐defined beams are deliverable with sub‐mm spatial accuracy. The QA procedure is practical for daily tests by therapists. PACS number(s): 87.53.Ly, 87.56.Fc
Collapse
|
43
|
Popple RA, Griffith HR, Sawrie SM, Fiveash JB, Brezovich IA. Implementation of Talairach Atlas Based Automated Brain Segmentation for Radiation Therapy Dosimetry. Technol Cancer Res Treat 2016; 5:15-21. [PMID: 16417398 DOI: 10.1177/153303460600500103] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Radiotherapy for brain cancer inevitably results in irradiation of uninvolved brain. While it has been demonstrated that irradiation of the brain can result in cognitive deficits, dose-volume relationships are not well established. There is little work correlating a particular cognitive deficit with dose received by the region of the brain responsible for the specific cognitive function. One obstacle to such studies is that identification of brain anatomy is both labor intensive and dependent on the individual performing the segmentation. Automatic segmentation has the potential to be both efficient and consistent. Brains2 is a software package developed by the University of Iowa for MRI volumetric studies. It utilizes MR images, the Talairach atlas, and an artificial neural network (ANN) to segment brain images into substructures in a standardized manner. We have developed a software package, Brains2DICOM, that converts the regions of interest identified by Brains2 into a DICOM radiotherapy structure set. The structure set can be imported into a treatment planning system for dosimetry. We demonstrated the utility of Brains2DICOM using a test case, a 34-year-old man with diffuse astrocytoma treated with three-dimensional conformal radiotherapy. Brains2 successfully applied the Talairach atlas to identify the right and left frontal, parietal, temporal, occipital, subcortical, and cerebellum regions. Brains2 was not successful in applying the ANN to identify small structures, such as the hippocampus and caudate. Further work is necessary to revise the ANN or to develop new methods for identification of small structures in the presence of disease and radiation induced changes. The segmented regions-of-interest were transferred to our commercial treatment planning system using DICOM and dose-volume histograms were constructed. This method will facilitate the acquisition of data necessary for the development of normal tissue complication probability (NTCP) models that assess the probability of cognitive complications secondary to radiotherapy for intracranial and head and neck neoplasms.
Collapse
Affiliation(s)
- R A Popple
- Department of Radiation Oncology, The University of Alabama at Birmingham, 35233, USA.
| | | | | | | | | |
Collapse
|
44
|
Thomas EM, Popple RA, Fiveash JB. SU-F-T-637: Single-Isocenter Versus Multiple-Isocenter VMAT SRS for Unusual Multiple Metastasis Case with Two Widely Separated Lesions. Med Phys 2016. [DOI: 10.1118/1.4956822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
45
|
Carver RL, Sprunger CP, Hogstrom KR, Popple RA, Antolak JA. Evaluation of the Eclipse eMC algorithm for bolus electron conformal therapy using a standard verification dataset. J Appl Clin Med Phys 2016; 17:52-60. [PMID: 27167259 PMCID: PMC5690899 DOI: 10.1120/jacmp.v17i3.5885] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2015] [Revised: 02/03/2016] [Accepted: 01/23/2016] [Indexed: 11/23/2022] Open
Abstract
The purpose of this study was to evaluate the accuracy and calculation speed of electron dose distributions calculated by the Eclipse electron Monte Carlo (eMC) algorithm for use with bolus electron conformal therapy (ECT). The recent commercial availability of bolus ECT technology requires further validation of the eMC dose calculation algorithm. eMC‐calculated electron dose distributions for bolus ECT have been compared to previously measured TLD‐dose points throughout patient‐based cylindrical phantoms (retromolar trigone and nose), whose axial cross sections were based on the mid‐PTV (planning treatment volume) CT anatomy. The phantoms consisted of SR4 muscle substitute, SR4 bone substitute, and air. The treatment plans were imported into the Eclipse treatment planning system, and electron dose distributions calculated using 1% and <0.2% statistical uncertainties. The accuracy of the dose calculations using moderate smoothing and no smoothing were evaluated. Dose differences (eMC‐calculated less measured dose) were evaluated in terms of absolute dose difference, where 100% equals the given dose, as well as distance to agreement (DTA). Dose calculations were also evaluated for calculation speed. Results from the eMC for the retromolar trigone phantom using 1% statistical uncertainty without smoothing showed calculated dose at 89% (41/46) of the measured TLD‐dose points was within 3% dose difference or 3 mm DTA of the measured value. The average dose difference was −0.21%, and the net standard deviation was 2.32%. Differences as large as 3.7% occurred immediately distal to the mandible bone. Results for the nose phantom, using 1% statistical uncertainty without smoothing, showed calculated dose at 93% (53/57) of the measured TLD‐dose points within 3% dose difference or 3 mm DTA. The average dose difference was 1.08%, and the net standard deviation was 3.17%. Differences as large as 10% occurred lateral to the nasal air cavities. Including smoothing had insignificant effects on the accuracy of the retromolar trigone phantom calculations, but reduced the accuracy of the nose phantom calculations in the high‐gradient dose areas. Dose calculation times with 1% statistical uncertainty for the retromolar trigone and nose treatment plans were 30 s and 24 s, respectively, using 16 processors (Intel Xeon E5‐2690, 2.9 GHz) on a framework agent server (FAS). In comparison, the eMC was significantly more accurate than the pencil beam algorithm (PBA). The eMC has comparable accuracy to the pencil beam redefinition algorithm (PBRA) used for bolus ECT planning and has acceptably low dose calculation times. The eMC accuracy decreased when smoothing was used in high‐gradient dose regions. The eMC accuracy was consistent with that previously reported for accuracy of the eMC electron dose algorithm and shows that the algorithm is suitable for clinical implementation of bolus ECT. PACS number(s): 87.55.kd
Collapse
Affiliation(s)
- Robert L Carver
- Mary Bird Perkins Cancer Center; Louisiana State University.
| | | | | | | | | |
Collapse
|
46
|
Thomas EM, Popple RA, Markert JM, Fiveash JB. In Reply: Volumetric Arc Therapy (RapidArc) vs Gamma Knife Radiosurgery for Multiple Brain Metastases: Not Only a Dosimetric Issue. Neurosurgery 2015; 77:E311. [PMID: 25951033 DOI: 10.1227/neu.0000000000000797] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Affiliation(s)
- Evan M Thomas
- Departments of *Radiation Oncology and ‡Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama
| | | | | | | |
Collapse
|
47
|
Popple RA, Balter PA, Orton CG. Point/Counterpoint. Because of the advantages of rotational techniques, conventional IMRT will soon become obsolete. Med Phys 2015; 41:100601. [PMID: 25281937 DOI: 10.1118/1.4885996] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
Affiliation(s)
- Richard A Popple
- Hazelrig-Salter Radiation Oncology Center, University of Alabama Birmingham, Birmingham, Alabama 35249-6832 (Tel: 205-934-1762; E-mail: )
| | - Peter A Balter
- Division of Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas 77030-0547 (Tel: 713-563-2560; E-mail: )
| | | |
Collapse
|
48
|
McDonald AM, Baker CB, Popple RA, Cardan RA, Fiveash JB. Increased radiation dose heterogeneity within the prostate predisposes to urethral strictures in patients receiving moderately hypofractionated prostate radiation therapy. Pract Radiat Oncol 2015; 5:338-342. [PMID: 25858771 DOI: 10.1016/j.prro.2015.02.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2014] [Revised: 02/06/2015] [Accepted: 02/19/2015] [Indexed: 10/23/2022]
Abstract
PURPOSE The purpose of this study was to determine whether radiation dose inhomogeneity within the prostate predisposes to late urinary strictures after moderately hypofractionated definitive external beam radiation therapy for prostate cancer. METHODS AND MATERIALS One hundred seventy-three men with clinically localized prostate cancer met the inclusion criteria for this analysis. All patients received 70 Gy to the prostate delivered over 28 fractions, had at least 2 years of clinical follow-up, and had dose-volume histogram information available for review. The endpoint of this study was the development of a urethral stricture that required a procedural intervention such as urethral dilation or suprapubic catheterization. Dosimetric parameters were evaluated for effect on the rate of urethral stricture formation by univariate Cox proportional hazards modeling. RESULTS The median follow-up was 49.5 months (range, 24.6-108 months). At 5 years, the actuarial rate of intervention for urethral strictures across all patients was 4.9%. The maximum point dose within the prostate (P = .034, hazard ratio = 1.006) and the mean prostate dose (P = .039, hazard ratio = 1.004) were the only parameters predictive of urethral stricture formation. All patients who developed a urethral stricture were treated by a plan with a maximum prostate dose of >75 Gy (median, 77.67 Gy). CONCLUSIONS For patients receiving moderately hypofractionated prostate radiation therapy over 28 fractions, a maximum point dose of 75 Gy within the prostate was associated with an increased probability of developing a urethral stricture that required procedural intervention. The hypothesis that hypofractionation increases susceptibility to toxicity from heterogeneity within the prostate should be confirmed by analyzing data from randomized trials with a conventionally fractionated control arm for comparison.
Collapse
Affiliation(s)
- Andrew M McDonald
- University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama.
| | | | - Richard A Popple
- University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama
| | - Rex A Cardan
- University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama
| | - John B Fiveash
- University of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, Alabama
| |
Collapse
|
49
|
Thomas EM, Popple RA, Markert JM, Fiveash JB. In reply: volumetric arc therapy (RapidArc) vs Gamma Knife radiosurgery for multiple brain metastases. Neurosurgery 2015; 76:E353-4. [PMID: 25621987 DOI: 10.1227/neu.0000000000000662] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Affiliation(s)
- Evan M Thomas
- *Department of Radiation Oncology ‡Department of Biomedical Engineering §Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama
| | | | | | | |
Collapse
|
50
|
Abstract
PURPOSE The selection of optimal beam geometry has been of interest since the inception of conformal radiotherapy. The authors report on sequential beam addition, a simple beam geometry selection method, for intensity modulated radiation therapy. METHODS The sequential beam addition algorithm (SBA) requires definition of an objective function (score) and a set of candidate beam geometries (pool). In the first iteration, the optimal score is determined for each beam in the pool and the beam with the best score selected. In the next iteration, the optimal score is calculated for each beam remaining in the pool combined with the beam selected in the first iteration, and the best scoring beam is selected. The process is repeated until the desired number of beams is reached. The authors selected three treatment sites, breast, lung, and brain, and determined beam arrangements for up to 11 beams from a pool comprised of 25 equiangular transverse beams. For the brain, arrangements were additionally selected from a pool of 22 noncoplanar beams. Scores were determined for geometries comprised equiangular transverse beams (EQA), as well as two tangential beams for the breast case. RESULTS In all cases, SBA resulted in scores superior to EQA. The breast case had the strongest dependence on beam geometry, for which only the 7-beam EQA geometry had a score better than the two tangential beams, whereas all SBA geometries with more than two beams were superior. In the lung case, EQA and SBA scores monotonically improved with increasing number of beams; however, SBA required fewer beams to achieve scores equivalent to EQA. For the brain case, SBA with a coplanar pool was equivalent to EQA, while the noncoplanar pool resulted in slightly better scores; however, the dose-volume histograms demonstrated that the differences were not clinically significant. CONCLUSIONS For situations in which beam geometry has a significant effect on the objective function, SBA can identify arrangements equivalent to equiangular geometries but using fewer beams. Furthermore, SBA provides the value of the objective function as the number of beams is increased, allowing the planner to select the minimal beam number that achieves the clinical goals. The method is simple to implement and could readily be incorporated into an existing optimization system.
Collapse
Affiliation(s)
- Richard A Popple
- Department of Radiation Oncology, The University of Alabama at Birmingham, 1720 2nd Avenue South, Birmingham, Alabama 35294
| | - Ivan A Brezovich
- Department of Radiation Oncology, The University of Alabama at Birmingham, 1720 2nd Avenue South, Birmingham, Alabama 35294
| | - John B Fiveash
- Department of Radiation Oncology, The University of Alabama at Birmingham, 1720 2nd Avenue South, Birmingham, Alabama 35294
| |
Collapse
|